,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,17,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
9,19,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
10,21,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
11,23,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
12,25,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
13,27,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
14,29,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
15,31,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
16,33,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
17,35,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
18,37,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
19,39,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
20,41,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
21,43,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
22,45,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
23,47,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
24,49,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
25,51,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
26,53,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
27,55,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
28,57,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
29,59,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
30,61,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
31,63,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
32,65,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
33,67,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
34,69,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
35,71,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
36,73,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
37,75,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
38,77,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
39,79,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
40,81,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
41,83,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
42,85,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
43,87,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
44,89,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line,Confirmatory,,
45,91,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
46,93,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
47,95,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
48,97,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Confirmatory,,
49,99,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
50,101,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
51,103,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
52,105,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
53,107,1,1,,87142,6758,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
54,109,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
55,113,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
56,115,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
57,119,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
58,121,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
59,123,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
60,125,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
61,129,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
62,131,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
63,133,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
64,135,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
65,137,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
66,139,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
67,141,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
68,143,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
69,145,1,1,,87142,6758,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
70,155,1,1,,87142,6758,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
71,157,1,1,,87142,6758,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
72,161,1,1,,87142,6758,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
73,165,1,1,,87142,6758,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
74,167,1,1,,87142,6758,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
75,175,1,1,,87142,6758,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
76,179,1,1,,87142,6758,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
77,180,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Adenocarcinoma 755 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
78,192,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
79,202,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (subcutaneous) in NU/NU Swiss (nude) mice,Other,,
80,206,1,1,,87142,6758,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
81,212,1,1,,87142,6758,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
82,220,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1,Other,,
83,248,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
84,262,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (subcutaneous) in NU/NU Swiss (nude) mice,Other,,
85,264,1,1,,87142,6758,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
86,270,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
87,292,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (intraperitoneal) in B6C3F1 mice,Other,,
88,294,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (subcutaneous) in NU/NU Swiss (nude) mice,Other,,
89,296,1,1,,87142,6758,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
90,328,1,1,,87142,6758,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
91,330,1,1,,74194,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
92,330,1,1,,87142,6758,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
93,377,1,3,,10321523,6758,Active,42741659.0,5243.0,,,MDR-1,Other,,
94,410,1,5,,11113277,6758,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
95,411,2,1,,11113277,6758,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
96,422,1,5,,17405668,6758,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
97,429,1,5,,17405668,6758,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
98,429,1,5,,17405668,6758,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
99,436,2,1,,17405668,6758,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
100,445,3,1,,11113277,6758,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
101,447,1,1,,11113277,6758,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
102,448,1,2,,11113277,6758,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
103,450,1,2,,11113277,6758,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
104,451,1,2,,11113277,6758,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
105,526,1,1,,11113277,6758,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
106,530,1,1,,11113277,6758,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
107,547,1,4,,17405668,6758,Inactive,16130533.0,947097.0,,,HTS for inhibitors of bacterial DnaK,Other,,
108,584,1,3,,11113277,6758,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
109,585,1,4,,11113277,6758,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
110,587,1,5,,11113277,6758,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
111,588,1,4,,11113277,6758,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
112,589,1,3,,11113277,6758,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
113,590,1,3,,11113277,6758,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
114,591,1,4,,11113277,6758,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
115,592,1,6,,11113277,6758,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
116,593,1,4,,11113277,6758,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
117,594,1,4,,11113277,6758,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
118,595,1,3,,11113277,6758,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
119,596,1,2,,11113277,6758,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
120,597,1,3,,11113277,6758,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
121,603,1,2,,11113277,6758,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
122,605,1,2,,11113277,6758,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
123,607,1,3,,11113277,6758,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
124,608,1,6,,11537425,6758,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
125,662,1,1,,11113277,6758,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
126,694,1,1,,17405668,6758,Inactive,118764400.0,2099.0,,,HTS of LOPAC library for Estrogen Receptor-alpha Coactivator Binding inhibitors,Confirmatory,,
127,732,1,2,,17405668,6758,Inactive,,,,,In Vivo Angiogenesis Assay for HTS,Screening,,
128,875,1,2,,26753651,6758,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
129,880,2,1,,26753651,6758,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
130,880,2,1,,26753651,6758,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
131,880,2,1,,26753652,6758,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
132,880,2,1,,26753652,6758,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
133,880,2,1,,50107017,6758,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
134,880,2,1,,50107017,6758,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
135,881,2,2,,26753651,6758,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
136,883,1,3,,11113277,6758,Inconclusive,13699818.0,1559.0,31.6228,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
137,884,1,2,,26753651,6758,Active,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
138,885,1,2,,26753651,6758,Inactive,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
139,886,1,2,,11113277,6758,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
140,886,1,2,,11113277,6758,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
141,887,1,2,,26753651,6758,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
142,889,1,3,,26753651,6758,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
143,891,1,2,,11113277,6758,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
144,892,1,2,,26753651,6758,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
145,893,1,2,,26753651,6758,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
146,893,1,2,,26753651,6758,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
147,894,2,1,,26753651,6758,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
148,894,2,1,,50107017,6758,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
149,899,1,2,,11113277,6758,Active,4503219.0,1557.0,1.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
150,900,1,3,,26753651,6758,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
151,901,1,2,,26753651,6758,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
152,902,1,2,,26753651,6758,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
153,912,1,2,,11113277,6758,Inconclusive,21392848.0,,6.3096,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
154,923,1,2,,26753651,6758,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
155,924,1,2,,26753651,6758,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
156,926,1,2,,11113277,6758,Inconclusive,38016895.0,7253.0,1.2589,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
157,938,1,2,,11113277,6758,Inconclusive,38016895.0,7253.0,1.2589,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
158,940,1,2,,17405668,6758,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
159,940,1,2,,26612995,6758,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
160,995,1,2,,26753651,6758,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
161,1030,2,1,,26753651,6758,Inconclusive,30582681.0,216.0,35.4813,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
162,1030,2,1,,50107017,6758,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
163,1033,2,2,,11537425,6758,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
164,1188,1,2,,48414968,6758,Active,,,,,DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity,Other,,
165,1189,1,5,,48414434,6758,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
166,1194,1,3,,48414434,6758,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
167,1199,1,3,,48414434,6758,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
168,1205,1,4,,48414434,6758,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
169,1208,1,3,,48414434,6758,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
170,1379,1,2,,26753651,6758,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
171,1379,1,2,,50107017,6758,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
172,1422,1,1,,17405668,6758,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
173,1422,1,1,,26612995,6758,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
174,1452,1,1,,26753651,6758,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
175,1454,1,1,,26753651,6758,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
176,1454,1,1,,50107017,6758,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
177,1457,1,1,,26753651,6758,Inactive,44888968.0,83523.0,25.1189,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
178,1457,1,1,,50107017,6758,Inactive,44888968.0,83523.0,31.6228,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
179,1458,1,1,,50107017,6758,Inactive,10937869.0,6607.0,0.0631,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
180,1459,1,1,,50107017,6758,Inconclusive,27436948.0,4000.0,2.8184,Potency,Validation of Assay for Modulators of Lamin A Splicing,Confirmatory,,
181,1460,1,3,,26753651,6758,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
182,1460,1,3,,50107017,6758,Inconclusive,92096784.0,4137.0,8.9125,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
183,1461,1,2,,50107017,6758,Inconclusive,46395496.0,387129.0,12.5893,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
184,1463,1,1,,26753651,6758,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
185,1463,1,1,,50107017,6758,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
186,1467,1,3,,26753651,6758,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
187,1467,1,3,,50107017,6758,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
188,1468,1,1,,26753651,6758,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
189,1468,1,1,,50107017,6758,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
190,1469,1,1,,26753651,6758,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
191,1469,1,1,,26753652,6758,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
192,1469,1,1,,50107017,6758,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
193,1471,2,1,,11113277,6758,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
194,1471,2,1,,26753651,6758,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
195,1471,2,1,,26753652,6758,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
196,1476,2,1,,26753651,6758,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
197,1476,2,1,,50107017,6758,Inconclusive,281307097.0,,39.8107,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
198,1477,1,1,,26753651,6758,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
199,1477,1,1,,50107017,6758,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
200,1478,2,1,,26753651,6758,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
201,1478,2,1,,50107017,6758,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
202,1479,1,2,,26753651,6758,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
203,1479,1,2,,26753652,6758,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
204,1479,1,2,,50107017,6758,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
205,1487,1,1,,26753652,6758,Inconclusive,27436948.0,4000.0,0.5012,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
206,1487,1,1,,50107017,6758,Inconclusive,27436948.0,4000.0,0.8913,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
207,1490,2,1,,26753651,6758,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
208,1490,2,1,,26753652,6758,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
209,1519,1,3,,26753651,6758,Inconclusive,,,14.1254,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
210,1519,1,3,,50107017,6758,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
211,1549,1,2,,11537425,6758,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
212,1552,1,3,,11537425,6758,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
213,1580,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
214,1581,1,1,,8149612,6758,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
215,1582,1,1,,8149612,6758,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
216,1583,1,1,,8149612,6758,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
217,1584,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
218,1585,1,1,,8149612,6758,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
219,1586,1,1,,8149612,6758,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
220,1587,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
221,1588,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
222,1589,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
223,1590,1,1,,8149612,6758,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
224,1593,1,1,,8149612,6758,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
225,1594,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
226,1595,1,1,,8149612,6758,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
227,1596,1,1,,8149612,6758,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
228,1597,1,1,,8149612,6758,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
229,1598,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
230,1599,1,1,,8149612,6758,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
231,1600,1,1,,8149612,6758,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
232,1601,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
233,1602,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
234,1603,1,1,,8149612,6758,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
235,1604,1,1,,8149612,6758,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
236,1605,1,1,,8149612,6758,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
237,1606,1,1,,8149612,6758,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
238,1607,1,1,,8149612,6758,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
239,1608,1,1,,8149612,6758,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
240,1609,1,1,,8149612,6758,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
241,1610,1,1,,8149612,6758,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
242,1612,1,1,,8149612,6758,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
243,1613,1,1,,8149612,6758,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
244,1614,1,1,,8149612,6758,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
245,1616,1,1,,8149612,6758,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
246,1637,1,2,,11537425,6758,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
247,1648,1,2,,11537425,6758,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
248,1688,1,1,,26753652,6758,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
249,1705,1,2,,50107017,6758,Inactive,6980812.0,,,Potency,qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1),Confirmatory,,
250,1707,1,3,,50107017,6758,Inactive,,,,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay,Confirmatory,,
251,1708,1,3,,50107017,6758,Inactive,405898.0,,,Potency,Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV,Confirmatory,,
252,1766,1,1,,26753651,6758,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
253,1766,1,1,,26753651,6758,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
254,1766,1,1,,26753652,6758,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
255,1766,1,1,,26753652,6758,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
256,1766,1,1,,50107017,6758,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
257,1766,1,1,,50107017,6758,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
258,1768,1,1,,26753651,6758,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
259,1768,1,1,,26753651,6758,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
260,1768,1,1,,26753652,6758,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
261,1768,1,1,,26753652,6758,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
262,1768,1,1,,50107017,6758,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
263,1768,1,1,,50107017,6758,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
264,1815,1,1,,50107017,6758,Active,,,11.2202,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8,Confirmatory,,
265,1816,1,1,,50107017,6758,Active,,,12.5893,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4,Confirmatory,,
266,1828,2,1,,50107017,6758,Inconclusive,,,,,qHTS for Inhibitors of Plasmodium falciparum proliferation: Summary,Summary,,
267,1865,1,1,,26753651,6758,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
268,1865,1,1,,50107017,6758,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
269,1876,1,1,,50107017,6758,Inconclusive,,,8.9125,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7,Confirmatory,,
270,1877,1,1,,50107017,6758,Inconclusive,,,11.2202,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10,Confirmatory,,
271,1882,1,1,,50107017,6758,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2,Confirmatory,,
272,1883,1,1,,50107017,6758,Active,,,8.9125,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2,Confirmatory,,
273,1886,1,1,,50107017,6758,Inconclusive,,,12.5893,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3,Confirmatory,,
274,1948,1,1,,26753651,6758,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
275,1948,1,1,,50107017,6758,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
276,1967,1,1,,85231344,6758,Inconclusive,4505907.0,5376.0,0.0478,Potency,qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity,Confirmatory,,
277,2101,1,1,,26753651,6758,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
278,2101,1,1,,50107017,6758,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
279,2107,1,1,,26753651,6758,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
280,2107,1,1,,50107017,6758,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
281,2112,1,1,,26753651,6758,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
282,2112,1,1,,50107017,6758,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
283,2147,1,1,,26753651,6758,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
284,2147,1,1,,50107017,6758,Inconclusive,221046486.0,,39.8107,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
285,2323,1,1,,50107017,6758,Inconclusive,254220970.0,,11.2202,Potency,qHTS Validation Assay for Identification of Novel General Anesthetics,Confirmatory,,
286,2326,1,1,,50107017,6758,Inconclusive,194352380.0,,39.8107,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
287,2353,1,3,,50107017,6758,Inactive,282403581.0,,,Potency,qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
288,2364,1,2,,50107017,6758,Inconclusive,4557365.0,641.0,22.3872,Potency,qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
289,2441,1,1,,50107017,6758,Active,,,0.631,Potency,Cell cycle validation with wells to cells screening paradigm,Confirmatory,,
290,2451,1,2,,26753651,6758,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
291,2451,1,2,,50107017,6758,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
292,2472,1,2,,26753651,6758,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
293,2517,2,1,,26753651,6758,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
294,2517,2,1,,50107017,6758,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
295,2528,1,2,,26753651,6758,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
296,2528,1,2,,26753652,6758,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
297,2528,1,2,,50107017,6758,Inconclusive,4557365.0,641.0,22.3872,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
298,2546,1,1,,26753651,6758,Inconclusive,188536040.0,19885.0,22.3872,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
299,2546,1,1,,26753652,6758,Inconclusive,188536040.0,19885.0,0.01,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
300,2549,1,1,,26753651,6758,Inconclusive,282403581.0,,3.1623,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
301,2549,1,1,,50107017,6758,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
302,2551,1,1,,26753651,6758,Inconclusive,188536040.0,19885.0,1.2589,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
303,2551,1,1,,26753652,6758,Inconclusive,188536040.0,19885.0,0.3162,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
304,2660,1,1,,90340839,6758,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
305,2662,2,1,,85231344,6758,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
306,2666,1,1,,90340839,6758,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
307,2667,1,1,,90340839,6758,Active,4826730.0,2475.0,0.0465,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
308,2668,1,1,,90340839,6758,Active,4826730.0,2475.0,0.0585,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
309,2675,1,1,,50107017,6758,Unspecified,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
310,2732,1,1,,17405668,6758,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
311,2774,1,3,,92303198,6758,Inactive,,,,,LOPAC Circadian Assay,Screening,,
312,78107,3,3,,103166269,6758,Unspecified,,,,,Compound was evaluated in vivo for collapse time in guinea pig anaphylaxis model at dose 5 mg/kg,Other,6106061.0,
313,78130,8,2,,103166269,6758,Unspecified,,,,,Compound was evaluated for the inhibitory activity against slow reacting substance of anaphylaxis (SRS-A) of guinea pig ileum,Other,6106061.0,
314,79366,3,3,,103166269,6758,Unspecified,,,,,Compound was evaluated for the inhibitory activity against Acetylcholine in guinea pig ileum,Other,6106061.0,
315,79367,3,3,,103166269,6758,Unspecified,,,,,Compound was evaluated for the inhibitory activity against Histamine in guinea pig ileum,Other,6106061.0,
316,79368,3,3,,103166269,6758,Unspecified,,,,,Compound was evaluated for the inhibitory activity against Serotonin in guinea pig ileum,Other,6106061.0,
317,90877,5,3,,103166269,6758,Unspecified,,,,,The compound was evaluated for the insecticidal activity against housefly with cytochrome P450 oxidase inhibitor piperonyl butoxide,Other,,
318,91009,4,3,,103166269,6758,Unspecified,,,,,The compound was evaluated for the insecticidal activity against housefly without cytochrome P450 oxidase inhibitor piperonyl butoxide,Other,,
319,144481,3,5,,103166269,6758,Unspecified,,,,,Inhibition of NADH:UBQ:DCIP reductase activity in parascaris mitochondrial particles,Other,7707312.0,
320,144482,5,4,,103166269,6758,Active,,,0.002,IC50,Tested for the ability to block NADH dehydrogenase in a preparation of submitochondrial particles obtained from blow fly flight muscle,Confirmatory,,
321,144487,3,5,,103166269,6758,Unspecified,,,,,Inhibition of NADH:UBQ:DCIP reductase activity in beef mitochondrial particles,Other,7707312.0,
322,144490,7,3,,103166269,6758,Active,,,0.0035,IC50,The compound was evaluated for the inhibition of NADH dehydrogenase,Confirmatory,,
323,144493,8,5,,103166269,6758,Active,548387.0,287014.0,0.0051,IC50,Inhibitory activity against NADH oxidase in beef heart mitochondrial complex I.,Confirmatory,14592516.0,
324,144493,8,5,,103166269,6758,Active,92090583.0,327702.0,0.0051,IC50,Inhibitory activity against NADH oxidase in beef heart mitochondrial complex I.,Confirmatory,14592516.0,
325,144494,3,11,,103166269,6758,Unspecified,548387.0,287014.0,,,Inhibitory potency against NADH oxidase with respect to compound 2c,Other,14592516.0,
326,144494,3,11,,103166269,6758,Unspecified,92090583.0,327702.0,,,Inhibitory potency against NADH oxidase with respect to compound 2c,Other,14592516.0,
327,144503,6,2,,103166269,6758,Active,,,0.0288,IC50,Inhibitory activity against NADH/DH oxidoreductase in beef heart mitochondrial complex I.,Confirmatory,14592516.0,
328,144504,3,6,,103166269,6758,Unspecified,,,,,Inhibitory potency against NADH/DH oxidoreductase with respect to rotenone,Other,14592516.0,
329,278884,3,5,,103166269,6758,Active,,,,,Increase in lactate production in primary human osteoblasts at 1 uM after 1 hr by ELISA,Other,17088489.0,
330,278885,3,6,,103166269,6758,Active,,,,,Increase in lactate production in MG63 cells at 1 uM after 1 hr by ELISA,Other,17088489.0,
331,288485,4,3,,103166269,6758,Active,,,0.0051,IC50,Inhibition of NADH-ubiquinone oxidoreductase assessed by NADH oxidase activity in beef heart submitochondrial particles,Confirmatory,17482824.0,
332,288486,8,1,,103166269,6758,Unspecified,,,161.0,ED50,Antitumor activity against human MCF7 cells after 24 hrs by MTT assay,Confirmatory,17482824.0,
333,288487,8,1,,103166269,6758,Active,,,15.0,ED50,Antitumor activity against human HepG2 cells after 24 hrs by MTT assay,Confirmatory,17482824.0,
334,288488,8,1,,103166269,6758,Unspecified,,,202.0,ED50,Antitumor activity against human HT29 cells after 24 hrs by MTT assay,Confirmatory,17482824.0,
335,288489,8,1,,103166269,6758,Active,,,26.0,ED50,Antitumor activity against human A549 cells after 24 hrs by MTT assay,Confirmatory,17482824.0,
336,288490,8,1,,103166269,6758,Unspecified,,,147.0,ED50,Antitumor activity against human MES-SA cells after 24 hrs by MTT assay,Confirmatory,17482824.0,
337,288491,8,1,,103166269,6758,Unspecified,,,214.0,ED50,Antitumor activity against doxorubucin-resistant human MES-SA/Dx5 cells by MTT assay after 24 hrs,Confirmatory,17482824.0,
338,297626,4,3,,103166269,6758,Active,,,0.016,IC50,Inhibition of bovine mitochondrial MC1,Confirmatory,17696417.0,
339,305677,3,4,,103166269,6758,Unspecified,,,,,Inhibition of invasion of human HT1080 cells at 1 uM after 24 hrs,Other,17158054.0,
340,305678,3,4,,103166269,6758,Unspecified,,,,,Inhibition of invasion of human HT1080 cells at 3 uM after 24 hrs,Other,17158054.0,
341,305679,3,4,,103166269,6758,Unspecified,,,,,Inhibition of invasion of human HT1080 cells at 10 uM after 24 hrs,Other,17158054.0,
342,305680,3,4,,103166269,6758,Unspecified,,,,,Inhibition of invasion of human HT1080 cells at 30 uM after 24 hrs,Other,17158054.0,
343,305681,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 1 uM after 24 hrs by MTT assay,Other,17158054.0,
344,305682,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 3 uM after 24 hrs by MTT assay,Other,17158054.0,
345,305683,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 10 uM after 24 hrs by MTT assay,Other,17158054.0,
346,305684,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 30 uM after 24 hrs by MTT assay,Other,17158054.0,
347,305685,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 1 uM after 48 hrs by MTT assay,Other,17158054.0,
348,305686,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 3 uM after 48 hrs by MTT assay,Other,17158054.0,
349,305687,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 10 uM after 48 hrs by MTT assay,Other,17158054.0,
350,305688,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 30 uM after 48 hrs by MTT assay,Other,17158054.0,
351,305689,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 1 uM after 72 hrs by MTT assay,Other,17158054.0,
352,305690,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 3 uM after 72 hrs by MTT assay,Other,17158054.0,
353,305691,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 10 uM after 72 hrs by MTT assay,Other,17158054.0,
354,305692,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 30 uM after 72 hrs by MTT assay,Other,17158054.0,
355,305693,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 1 uM after 24 hrs by calcein-AM assay,Other,17158054.0,
356,305694,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 3 uM after 24 hrs by calcein-AM assay,Other,17158054.0,
357,305695,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 10 uM after 24 hrs by calcein-AM assay,Other,17158054.0,
358,305696,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 30 uM after 24 hrs by calcein-AM assay,Other,17158054.0,
359,305697,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 1 uM after 48 hrs by calcein-AM assay,Other,17158054.0,
360,305698,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 3 uM after 48 hrs by calcein-AM assay,Other,17158054.0,
361,305699,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 10 uM after 48 hrs by calcein-AM assay,Other,17158054.0,
362,305700,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 30 uM after 48 hrs by calcein-AM assay,Other,17158054.0,
363,305701,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 1 uM after 72 hrs by calcein-AM assay,Other,17158054.0,
364,305702,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 3 uM after 72 hrs by calcein-AM assay,Other,17158054.0,
365,305703,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 10 uM after 72 hrs by calcein-AM assay,Other,17158054.0,
366,305704,3,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human HT1080 cells at 30 uM after 72 hrs by calcein-AM assay,Other,17158054.0,
367,305705,3,4,,103166269,6758,Active,,,,,Inhibition of proMMP2 production in human HT1080 cells by gelatin zymography analysis,Other,17158054.0,
368,305706,3,4,,103166269,6758,Active,,,,,Inhibition of proMMP9 production in human HT1080 cells by gelatin zymography analysis,Other,17158054.0,
369,305715,6,2,,103166269,6758,Active,,,13.0,IC50,Antiproliferative activity against human U937 cells after 24 hrs by WST-8 assay,Confirmatory,17158054.0,
370,305716,6,2,,103166269,6758,Active,,,0.2,IC50,Antiproliferative activity against human U937 cells after 48 hrs by WST-8 assay,Confirmatory,17158054.0,
371,305717,6,2,,103166269,6758,Active,,,0.07,IC50,Antiproliferative activity against human U937 cells after 72 hrs by WST-8 assay,Confirmatory,17158054.0,
372,329493,3,3,,103166269,6758,Active,,,,,Cell death rescue in rat striatal neuronal N548 mutant cells by calcein acetoxymethyl ester assay,Other,17726098.0,
373,329494,3,3,,103166269,6758,Active,,,,,Cell death rescue in rat striatal neuronal N548 mutant cells analysed every day for 7 days at 10 uM by trypan blue dye-exclusion assay,Other,17726098.0,
374,329495,3,3,,103166269,6758,Unspecified,,,,,Decrease in htt expression in rat striatal neuron N548 mutant cells assessed as visible htt aggregation after 12 hrs by Western blotting,Other,17726098.0,
375,329496,6,2,,103166269,6758,Active,,,0.5,EC50,Cell death rescue in rat striatal neuron N548 mutant cells,Confirmatory,17726098.0,
376,329497,7,1,,103166269,6758,Active,,,,EC50,Toxicity in Caenorhabditis elegans Huntington's disease model,Confirmatory,17726098.0,
377,329498,8,1,,103166269,6758,Unspecified,,,50.0,TC50,Toxicity in drosophila Huntington's disease model,Confirmatory,17726098.0,
378,329499,6,2,,103166269,6758,Active,,,2.0,EC50,Cell death rescue of ASH neuronal cells in Caenorhabditis elegans Huntington's disease model,Confirmatory,17726098.0,
379,329500,3,3,,103166269,6758,Active,,,,,Decrease in rhabdomere degeneration in Drosophila photoreceptor assessed as number of rhabdomeres per ommatidium at day 9,Other,17726098.0,
380,329501,3,3,,103166269,6758,Active,,,,,Suppression of cell death in rat striatal neuronal N548 mutant cells assessed as suppression of caspase 3 activation by Western blotting,Other,17726098.0,
381,329502,3,3,,103166269,6758,Active,,,,,Suppression of cell death in rat striatal neuronal N548 mutant cells assessed as suppression of caspase 7 activation by Western blotting,Other,17726098.0,
382,329503,3,4,,103166269,6758,Inactive,,,,,Decrease in ATP levels in rat striatal neuronal N548 mutant cells after 8 hrs in serum-deprived medium by luminescence-based assay in presence of glucose,Other,17726098.0,
383,329504,3,3,,103166269,6758,Unspecified,,,,,Effect of NADH accumulation on cell death rescue in rat striatal neuronal N548 mutant cells by trypan blue dye-exclusion assay,Other,17726098.0,
384,329505,3,3,,103166269,6758,Unspecified,,,,,Effect of ROS levels on cell death rescue in rat striatal neuronal N548 mutant cells after 2 hrs,Other,17726098.0,
385,329506,3,3,,103166269,6758,Active,,,,,Activation of ERK in rat striatal neuronal N548 mutant cells at 10 uM by Western blotting,Other,17726098.0,
386,329507,3,3,,103166269,6758,Active,,,,,Activation of AKT in rat striatal neuronal N548 mutant cells at 10 uM by Western blotting,Other,17726098.0,
387,329508,3,9,,103166269,6758,Inactive,2499669.0,24514.0,,,Activation of JAK2 in rat striatal neuronal N548 mutant cells,Other,17726098.0,
388,329509,3,4,,103166269,6758,Inactive,,,,,Activation of NF-kappaB in rat striatal neuronal N548 mutant cells,Other,17726098.0,
389,329510,3,3,,103166269,6758,Inactive,,,,,Activation of p38 MAPK in rat striatal neuronal N548 mutant cells,Other,17726098.0,
390,329511,3,10,,103166269,6758,Inactive,125373.0,50686.0,,,Activation of GSKalpha in rat striatal neuronal N548 mutant cells,Other,17726098.0,
391,329512,3,10,,103166269,6758,Inactive,125374.0,84027.0,,,Activation of GSKbeta in rat striatal neuronal N548 mutant cells,Other,17726098.0,
392,329513,3,3,,103166269,6758,Unspecified,,,,,Activation of ERK in rat striatal neuronal N548 mutant cells after 8 hrs by Western blotting,Other,17726098.0,
393,329514,3,3,,103166269,6758,Unspecified,,,,,Activation of AKT in rat striatal neuronal N548 mutant cells after 8 hrs by Western blotting,Other,17726098.0,
394,329515,3,3,,103166269,6758,Active,,,,,Activation of ERK in rat striatal neuronal N548 mutant cells at 50 uM by Western blotting,Other,17726098.0,
395,329516,3,3,,103166269,6758,Active,,,,,Activation of AKT in rat striatal neuronal N548 mutant cells at 50 uM by Western blotting,Other,17726098.0,
396,329518,3,3,,103166269,6758,Active,,,,,Activation of AKT in DNA-deficient rat striatal neuronal N548 mutant cells at 10 uM after 6 hrs by Western blotting,Other,17726098.0,
397,329519,3,3,,103166269,6758,Active,,,,,Cell death rescue in DNA-deficient rat striatal neuronal N548 mutant cells at 10 uM,Other,17726098.0,
398,329520,3,3,,103166269,6758,Inactive,,,,,Cell death rescue in rat striatal neuronal N548 mutant cells at 10 uM after 2 days by calcein acetoxymethyl ester assay in presence of LY-294002,Other,17726098.0,
399,329521,3,3,,103166269,6758,Inactive,,,,,Cell death rescue in rat striatal neuronal N548 mutant cells at 10 uM after 2 days by calcein acetoxymethyl ester assay in presence of U0126,Other,17726098.0,
400,329522,6,2,,103166269,6758,Active,,,10.0,EC50,Cell death rescue of neuronal cells in drosophila Huntington's disease model,Confirmatory,17726098.0,
401,329523,8,1,,103166269,6758,Active,,,40.0,TC50,Toxicity in rat striatal neuronal N548 mutant cells,Confirmatory,17726098.0,
402,334001,10,1,,103166269,6758,Inconclusive,,,,,Toxicity to brine shrimp,Other,9322367.0,
403,334002,7,2,,103166269,6758,Unspecified,,,,,Insecticidal activity against yellow fever mosquito larvae by microtiter plate assay,Other,9322367.0,
404,334003,11,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human A549 cells after 7 days by MTT assay,Other,9322367.0,
405,334004,10,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human MCF7 cells after 7 days by MTT assay,Other,9322367.0,
406,334005,10,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human HT29 cells after 7 days by MTT assay,Other,9322367.0,
407,334006,8,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human A498 cells after 7 days by MTT assay,Other,9322367.0,
408,334007,11,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human PC3 cells after 7 days by MTT assay,Other,9322367.0,
409,334008,11,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human MIAPaCa2 cells after 7 days by MTT assay,Other,9322367.0,
410,334258,6,2,,103166269,6758,Unspecified,,,,,Antibacterial activity against Helicobacter pylori 31A after 48 hrs by serial doubling dilution method,Other,11975515.0,
411,334259,3,3,,103166269,6758,Inactive,,,,,Antibacterial activity against Bacillus subtilis ATCC 6633 at 625 ug/mL after 24 hrs by conventional well agar method,Other,11975515.0,
412,334260,3,3,,103166269,6758,Inactive,,,,,Antibacterial activity against Micrococcus luteus ATCC 9341 at 625 ug/mL after 24 hrs by conventional well agar method,Other,11975515.0,
413,334261,3,3,,103166269,6758,Inactive,,,,,Antibacterial activity against Bacteroides fragilis ATCC 25285 at 625 ug/mL after 24 hrs by conventional well agar method,Other,11975515.0,
414,334262,3,3,,103166269,6758,Inactive,,,,,Antibacterial activity against Escherichia coli ATCC 10536 at 625 ug/mL after 24 hrs by conventional well agar method,Other,11975515.0,
415,334263,3,3,,103166269,6758,Inactive,,,,,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 at 625 ug/mL after 24 hrs by conventional well agar method,Other,11975515.0,
416,334264,3,3,,103166269,6758,Inactive,,,,,Antifungal activity against Candida albicans ATCC 10231 at 625 ug/mL after 24 hrs by conventional well agar method,Other,11975515.0,
417,337265,5,1,,103166269,6758,Unspecified,,,,,Cytotoxicity against human BC1 cells after 72 hrs,Other,2614425.0,
418,337266,5,1,,103166269,6758,Unspecified,,,,,Cytotoxicity against human Col2 cells after 72 hrs,Other,2614425.0,
419,337267,5,1,,103166269,6758,Unspecified,,,,,Cytotoxicity against human HT1080 cells after 48 hrs,Other,2614425.0,
420,337268,5,1,,103166269,6758,Unspecified,,,,,Cytotoxicity against human Lu1 cells,Other,2614425.0,
421,337269,5,1,,103166269,6758,Unspecified,,,,,Cytotoxicity against human SK-MEL-2 cells after 72 hrs,Other,2614425.0,
422,337270,5,1,,103166269,6758,Unspecified,,,,,Cytotoxicity against human KB cells after 72 hrs,Other,2614425.0,
423,337271,5,1,,103166269,6758,Unspecified,,,,,Cytotoxicity against mouse P388 cells after 48 hrs,Other,2614425.0,
424,338271,3,5,,103166269,6758,Inactive,,,,,Antimicrobial activity against Escherichia coli DSM 1103 after 18 hrs by twofold serial dilution method,Other,7714539.0,
425,338272,3,5,,103166269,6758,Inactive,,,,,Antimicrobial activity against Pseudomonas aeruginosa DSM 1117 after 18 hrs by twofold serial dilution method,Other,7714539.0,
426,338274,6,3,,103166269,6758,Unspecified,,,,,Toxicity against Gambusia affinis,Other,7714539.0,
427,360869,5,3,,103166269,6758,Unspecified,,,,,Larvicidal activity against Aedes aegypti larvae assessed as minimum concentration required to kill all larvae after 24 hrs by dilution test,Other,11421729.0,
428,370978,6,2,,103166269,6758,Unspecified,,,10.0,IC50,Inhibition of Plasmodium falciparum NDH2,Confirmatory,19097788.0,
429,370979,9,5,,103166269,6758,Unspecified,74850260.0,,10.0,IC50,Inhibition of Plasmodium falciparum DHOD,Confirmatory,19097788.0,
430,370980,6,7,,103166269,6758,Unspecified,131723.0,853664.0,10.0,IC50,Inhibition of Saccharomyces cerevisiae DHOD,Confirmatory,19097788.0,
431,370981,6,2,,103166269,6758,Unspecified,,,10.0,IC50,Antimalarial activity against Plasmodium falciparum DD2 by [3H]hypoxanthine uptake,Confirmatory,19097788.0,
432,370982,6,2,,103166269,6758,Unspecified,,,10.0,IC50,Antimalarial activity against Plasmodium falciparum DD2 expressing Saccharomyces cerevisiae DHOD by [3H]hypoxanthine uptake,Confirmatory,19097788.0,
433,377926,7,2,,103166269,6758,Inconclusive,,,,,Toxicity in brine shrimp,Other,9917277.0,
434,377927,7,2,,103166269,6758,Unspecified,,,,,Pesticidal activity against yellow fever mosquito larvae by microtiter plate assay,Other,9917277.0,
435,377928,9,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human A549 cells by MTT assay,Other,9917277.0,
436,377929,11,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human MCF7 cells by MTT assay,Other,9917277.0,
437,377930,11,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human HT-29 cells by MTT assay,Other,9917277.0,
438,377931,11,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human A-498 cells by MTT assay,Other,9917277.0,
439,377932,11,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human PC-3 cells by MTT assay,Other,9917277.0,
440,377933,11,1,,103166269,6758,Inconclusive,,,,,Cytotoxicity against human PaCa2 cells by MTT assay,Other,9917277.0,
441,380415,3,3,,103166269,6758,Unspecified,,,,,Antifeedant effect against Spodoptera littoralis assessed as feeding reduction at 100 ug/cm2 relative to control,Other,10869199.0,
442,380472,6,2,,103166269,6758,Unspecified,,,,,Cytotoxicity against human MCF7 cells after 3 days by SRB assay,Other,16562843.0,
443,380473,6,2,,103166269,6758,Unspecified,,,,,Cytotoxicity against human A549 cells after 3 days by SRB assay,Other,16562843.0,
444,380667,3,3,,103166269,6758,Unspecified,,,,,Antifeedant effect against Myzus persicae assessed as inhibition index at 100 ug/cm2 relative to control,Other,10869199.0,
445,380669,3,3,,103166269,6758,Unspecified,,,,,Antifeedant effect against Leptinotarsa decemlineata assessed as feeding reduction at 10 ug/cm2,Other,10869199.0,
446,380672,3,3,,103166269,6758,Unspecified,,,,,"Antifeedant effect against Spodoptera littoralis L6 larvae assessed as relative consumption rate at 10 ug, po after 72 hrs",Other,10869199.0,
447,380673,3,3,,103166269,6758,Unspecified,,,,,"Antifeedant effect against Spodoptera littoralis L6 larvae assessed as relative growth rate at 10 ug, po after 72 hrs",Other,10869199.0,
448,380674,3,3,,103166269,6758,Unspecified,,,,,Insecticidal activity against Leptinotarsa decemlineata assessed as mortality at 5 ug by hemolymph injection after 72 hrs,Other,10869199.0,
449,380675,3,3,,103166269,6758,Unspecified,,,,,Insecticidal activity against Myzus persicae assessed as increase in mortality at 100 ug/cm2 observed daily for 4 days,Other,10869199.0,
450,380676,3,3,,103166269,6758,Unspecified,,,,,Insecticidal activity against Myzus persicae assessed as increase in mortality at 50 ug/cm2 observed daily for 4 days,Other,10869199.0,
451,380677,3,3,,103166269,6758,Unspecified,,,,,Insecticidal activity against Myzus persicae assessed as offspring production at 100 ug/cm2 observed daily for 4 days,Other,10869199.0,
452,380678,3,3,,103166269,6758,Unspecified,,,,,Insecticidal activity against Myzus persicae assessed as offspring production at 50 ug/cm2 observed daily for 4 days,Other,10869199.0,
453,397122,6,3,,103166269,6758,Unspecified,,,,,Inhibition of HIV1 RT,Other,1710653.0,
454,398321,7,4,,103166269,6758,Active,,,34.0,IC50,Inhibition of respiration in rat liver mitochondria assessed per mg of protein,Confirmatory,7623031.0,
455,400539,6,2,,103166269,6758,Unspecified,,,,,Cytotoxicity against human A2780 cells,Other,15043430.0,
456,401113,9,1,,103166269,6758,Inconclusive,,,,,Toxicity in Artemia salina,Other,9644064.0,
457,401114,10,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against yellow fever mosquito larvae transfected in bovine liver powder after 4 days by MES assay,Other,9644064.0,
458,404304,3,10,,103166269,6758,Unspecified,308153583.0,1244.0,,,Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control,Other,18457386.0,
459,404809,3,4,,103166269,6758,Active,,,,,Antiproliferative activity against human U373 MG cells after 72 hrs,Other,18513974.0,
460,407933,4,3,,103166269,6758,Active,,,0.016,IC50,Inhibition of mitochondrial complex 1 in bovine heart mitochondria assessed as effect on rate of NADH oxidation,Confirmatory,18422306.0,
461,422949,3,3,,103166269,6758,Active,,,,,Antiparasitic activity against Echinococcus multilocularis protoscolex at 5 uM after 5 days by trypan blue staining,Other,17954696.0,
462,427711,8,1,,103166269,6758,Active,,,0.0051,IC50,Inhibition of NADH oxidase in beef heart submitochondrial particles by end-window spectrophotometry,Confirmatory,19719247.0,
463,463096,1,1,,50107017,6758,Active,,,5.6234,Potency,Validation screen for inhibitors of Lassa infection,Confirmatory,,
464,463097,1,1,,50107017,6758,Active,7705682.0,51053.0,1.4125,Potency,Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells,Confirmatory,,
465,463106,1,2,,90340839,6758,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
466,463189,1,1,,53778218,6758,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
467,478214,3,3,,103166269,6758,Active,,,0.00436,IC50,Inhibition of NADH oxidase from beef heart submitochondrial particles by spectrophotometry,Confirmatory,20456960.0,
468,478215,3,3,,103166269,6758,Inconclusive,,,,IC50,Inhibition of NADH-ubiquinone oxidoreductase from beef heart submitochondrial particles by spectrophotometry,Confirmatory,20456960.0,
469,479263,8,1,,103166269,6758,Unspecified,,,,,Larvicidal activity against Aedes aegypti fourth instar larvae after 24 hrs,Other,20347303.0,
470,480185,4,4,,103166269,6758,Unspecified,,,,,Inhibition of mitochondrial respiratory chain complex 1 in human T47D cells assessed as decrease in oxygen consumption,Other,20423107.0,
471,485290,1,1,,26753651,6758,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
472,485290,1,1,,26753652,6758,Inconclusive,20150581.0,,0.005,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
473,485290,1,1,,50107017,6758,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
474,485295,1,2,,90340839,6758,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
475,485297,1,1,,90340839,6758,Inactive,4759012.0,9367.0,73.078,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
476,485298,1,1,,90340839,6758,Active,,,18.3564,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
477,485313,1,2,,90340839,6758,Inactive,255652944.0,4864.0,290.92900000000003,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
478,485314,1,1,,50107017,6758,Inconclusive,4505931.0,5423.0,39.8107,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
479,485342,1,2,,90340839,6758,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
480,485345,1,2,,90340839,6758,Inconclusive,,,25.929000000000002,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
481,485366,1,2,,90340839,6758,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
482,485368,1,2,,90340839,6758,Inconclusive,72386991.0,3656265.0,0.8492,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
483,488745,1,4,,85231344,6758,Inconclusive,,,16.5113,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
484,488752,1,4,,85231344,6758,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
485,488772,1,1,,90340839,6758,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
486,488773,1,2,,90340839,6758,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
487,488816,1,1,,90340839,6758,Inactive,4758356.0,2237.0,,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
488,488837,1,1,,90340839,6758,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
489,488949,1,2,,85231344,6758,Inactive,41055989.0,54737.0,0.8913,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
490,488949,1,2,,90340839,6758,Inconclusive,41055989.0,54737.0,37.6858,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
491,488953,1,1,,90340839,6758,Active,187960037.0,10951.0,35.4813,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
492,488978,1,1,,90340839,6758,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
493,488979,1,1,,50107017,6758,Inactive,74315350.0,7442.0,,Potency,HTS Assay for Compounds that Act as Enhancers of the Vanilloid Receptor 1,Confirmatory,,
494,488980,1,1,,85231344,6758,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
495,488981,1,1,,90340839,6758,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
496,488982,1,1,,90340839,6758,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
497,488983,1,1,,90340839,6758,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
498,492967,1,2,,99302035,6758,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
499,493106,1,1,,90340839,6758,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
500,493107,1,1,,90340839,6758,Inconclusive,116283940.0,79915.0,0.231,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
501,493127,1,1,,50107017,6758,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Validation Screen for Agonists,Screening,,
502,493153,1,1,,90340839,6758,Inconclusive,,4780.0,2.3109,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
503,493153,1,1,,90340839,6758,Inconclusive,224028257.0,4780.0,2.3109,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
504,493162,1,2,,99302035,6758,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
505,493164,1,2,,90340839,6758,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
506,493164,1,2,,90340839,6758,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
507,493164,1,2,,90340839,6758,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
508,493165,1,2,,85231344,6758,Active,,51053.0,1.0659,Potency,Retest of LOPAC molecules that induce DNA re-replication in SW480 adenocarcinoma cells.,Confirmatory,,
509,493165,1,2,,85231344,6758,Active,7705682.0,51053.0,1.0659,Potency,Retest of LOPAC molecules that induce DNA re-replication in SW480 adenocarcinoma cells.,Confirmatory,,
510,493166,1,2,,85231344,6758,Active,,51053.0,0.7546,Potency,Retest of LOPAC molecules that induce DNA re-replication in MCF 10A normal breast cells.,Confirmatory,,
511,493166,1,2,,85231344,6758,Active,7705682.0,51053.0,0.7546,Potency,Retest of LOPAC molecules that induce DNA re-replication in MCF 10A normal breast cells.,Confirmatory,,
512,493189,1,1,,50107017,6758,Inactive,4503895.0,2584.0,,Potency,qHTS Validation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
513,500914,3,3,,103166269,6758,Active,,,,,Inhibition of heat-induced AML1-ETO protein expression in heterozygous transgenic zebrafish embryo at 0.15 uM by Western blot analysis,Other,19172146.0,
514,500918,3,3,,103166269,6758,Active,,,,,Inhibition of Hsp70 expression in heterozygous transgenic zebrafish embryo at 0.15 uM by Western blot analysis,Other,19172146.0,
515,503309,2,5,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human PC3 cells at 300 nM after 120 hrs by MTT assay relative to DMSO,Other,16680159.0,
516,503332,2,6,,103166269,6758,Active,,,,,Effect on Cdc2 expressed in HEK293 cells assessed as effect on Cdc2:Cdc25C interaction complexes in presence of camptothecin by EYFP and/or YFP Venus fragment based reporter gene assay,Other,16680159.0,
517,503333,2,6,,103166269,6758,Active,,,,,Effect on Cdc2 expressed in HEK293 cells assessed as effect on Cdc2:Cdc25A interaction complexes in presence of camptothecin by EYFP and/or YFP Venus fragment based reporter gene assay,Other,16680159.0,
518,503334,2,6,,103166269,6758,Active,,,,,Effect on p53 expressed in HEK293 cells assessed as effect on p53-p53 interaction complexes in presence of camptothecin by EYFP and/or YFP Venus fragment based reporter gene assay,Other,16680159.0,
519,503335,2,6,,103166269,6758,Active,,,,,Inhibition of of c-Jun expressed in HEK293 cells assessed as induction of protein interaction in presence of camptothecin with Pin1 by EYFP based reporter gene assay,Other,16680159.0,
520,503336,2,6,,103166269,6758,Active,,,,,Effect on cofilin1 expressed in HEK293 cells assessed as effect on cofilin1; Limk2 interaction complexes in presence of camptothecin by EYFP and/or YFP Venus fragment based reporter gene assay,Other,16680159.0,
521,504327,1,1,,90340839,6758,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
522,504332,1,1,,50107017,6758,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
523,504332,1,1,,90340839,6758,Inconclusive,168985070.0,,23.7781,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
524,504364,1,1,,85231344,6758,Active,7705682.0,51053.0,0.92,Potency,Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells,Confirmatory,,
525,504536,1,1,,90340839,6758,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
526,504547,1,1,,90340839,6758,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
527,504548,1,2,,90340839,6758,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
528,504749,1,3,,26753652,6758,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
529,504749,1,3,,104171353,6758,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
530,504749,1,3,1.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
531,504749,1,3,2.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
532,504749,1,3,3.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
533,504749,1,3,4.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
534,504749,1,3,5.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
535,504749,1,3,6.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
536,504749,1,3,7.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
537,504749,1,3,8.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
538,504749,1,3,9.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
539,504749,1,3,10.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
540,504749,1,3,11.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
541,504749,1,3,12.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
542,504749,1,3,13.0,26753652,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
543,504749,1,3,14.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
544,504749,1,3,15.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
545,504749,1,3,16.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
546,504749,1,3,17.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
547,504749,1,3,18.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
548,504749,1,3,19.0,26753652,6758,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
549,504749,1,3,20.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
550,504749,1,3,21.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
551,504749,1,3,22.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
552,504749,1,3,23.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
553,504749,1,3,24.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
554,504749,1,3,25.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
555,504749,1,3,26.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
556,504749,1,3,27.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
557,504749,1,3,28.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
558,504749,1,3,29.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
559,504749,1,3,30.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
560,504749,1,3,31.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
561,504749,1,3,32.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
562,504749,1,3,33.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
563,504749,1,3,34.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
564,504749,1,3,35.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
565,504749,1,3,36.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
566,504749,1,3,37.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
567,504749,1,3,38.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
568,504749,1,3,39.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
569,504749,1,3,40.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
570,504749,1,3,41.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
571,504749,1,3,42.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
572,504749,1,3,43.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
573,504749,1,3,44.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
574,504749,1,3,45.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
575,504749,1,3,46.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
576,504749,1,3,47.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
577,504749,1,3,48.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
578,504749,1,3,49.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
579,504749,1,3,50.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
580,504749,1,3,51.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
581,504749,1,3,52.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
582,504749,1,3,53.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
583,504749,1,3,54.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
584,504749,1,3,55.0,104171353,6758,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
585,504749,1,3,56.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
586,504749,1,3,57.0,26753652,6758,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
587,504749,1,3,58.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
588,504749,1,3,59.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
589,504749,1,3,60.0,104171353,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
590,504749,1,3,61.0,26753652,6758,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
591,504810,1,2,,90340839,6758,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
592,504812,1,2,,90340839,6758,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
593,504821,1,1,,85231344,6758,Inactive,38016895.0,7253.0,,Potency,Antagonists of the Thyroid Stimulating Hormone Receptor: Validation,Confirmatory,,
594,504832,1,1,,104171353,6758,Inconclusive,,,10.690999999999999,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
595,504834,1,1,,104171353,6758,Active,,,6.7456,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
596,504836,1,2,,90340839,6758,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
597,504845,1,1,,90340839,6758,Inconclusive,86301163.0,5999.0,21.1923,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
598,504847,1,1,,90340839,6758,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
599,504847,1,1,,104171353,6758,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
600,504865,1,1,,90340839,6758,Inconclusive,118600387.0,7398.0,39.8107,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
601,504865,1,1,,104171353,6758,Inconclusive,118600387.0,7398.0,56.2341,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
602,513935,2,3,,103166269,6758,Unspecified,,,,,Neurotoxicity in Wistar rat cerebellar granule neurons assessed as cell death at 10 nM after 24 hrs using propidium iodide and Hoescht 33342 staining,Other,20637638.0,
603,513936,2,3,,103166269,6758,Unspecified,,,,,Neurotoxicity in Wistar rat cerebellar granule neurons assessed as attached dead cells at 0.1 uM after 24 hrs using propidium iodide and Hoescht 33342 staining,Other,20637638.0,
604,521220,3,3,,103166269,6758,Active,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
605,524790,7,2,,103166269,6758,Active,,,10.0,IC50,Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
606,524791,7,2,,103166269,6758,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
607,524792,7,2,,103166269,6758,Active,,,12.5893,IC50,Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
608,524794,7,1,,103166269,6758,Active,,,10.0,IC50,Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
609,524795,7,2,,103166269,6758,Active,,,10.0,IC50,Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
610,524796,7,1,,103166269,6758,Active,,,10.0,IC50,Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
611,540256,1,2,,50107017,6758,Active,,,5.6234,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
612,540256,1,2,,90340839,6758,Active,,,2.31,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
613,540276,1,2,,11113277,6758,Active,420597.0,,0.5802,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
614,540276,1,2,,26753651,6758,Active,420597.0,,0.7079,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
615,540276,1,2,,26753652,6758,Active,420597.0,,0.7079,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
616,540276,1,2,,50107017,6758,Active,420597.0,,0.7079,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
617,540276,1,2,,50107018,6758,Active,420597.0,,0.7079,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
618,540276,1,2,,50107019,6758,Active,420597.0,,0.7079,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
619,540276,1,2,,90340839,6758,Active,420597.0,,0.5802,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
620,588209,2,3,,103166269,6758,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
621,588210,2,4,,103166269,6758,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
622,588349,1,1,,90340839,6758,Inconclusive,,,22.3872,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
623,588378,1,1,,90340839,6758,Inconclusive,171543895.0,6311.0,0.2512,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
624,588379,1,2,,124883112,6758,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
625,588453,1,1,,85231344,6758,Inconclusive,8659577.0,58819.0,21.1923,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
626,588453,1,1,,90340839,6758,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
627,588456,1,1,,90340839,6758,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
628,588513,1,1,,26753652,6758,Inconclusive,348019627.0,2099.0,17.7828,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
629,588514,1,1,,26753652,6758,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
630,588515,1,1,,26753652,6758,Inconclusive,124375976.0,367.0,0.4467,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
631,588516,1,1,,26753652,6758,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
632,588526,1,1,,26753652,6758,Inconclusive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
633,588527,1,1,,26753652,6758,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
634,588532,1,1,,26753652,6758,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
635,588533,1,1,,26753652,6758,Inconclusive,311348376.0,2908.0,0.0501,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
636,588534,1,1,,26753652,6758,Inconclusive,216409690.0,5467.0,14.1254,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
637,588535,1,1,,26753652,6758,Inconclusive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
638,588536,1,1,,26753652,6758,Inconclusive,216409692.0,5468.0,31.6228,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
639,588537,1,1,,26753652,6758,Active,216409692.0,5468.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
640,588541,1,1,,26753652,6758,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
641,588543,1,1,,26753652,6758,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
642,588544,1,1,,26753652,6758,Inconclusive,325495497.0,6256.0,0.3548,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
643,588545,1,1,,26753652,6758,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
644,588546,1,1,,26753652,6758,Active,325495497.0,6256.0,19.9526,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
645,588547,1,1,,26753652,6758,Inconclusive,189491771.0,7068.0,12.5893,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
646,588579,1,1,,90340839,6758,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
647,588579,1,1,,104171353,6758,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
648,588579,1,1,,124883112,6758,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
649,588590,1,1,,50107017,6758,Inconclusive,154350220.0,11201.0,22.3872,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
650,588591,1,1,,50107017,6758,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
651,588795,1,1,,90340839,6758,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
652,588834,2,1,,26753652,6758,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
653,588834,2,1,,50107017,6758,Inconclusive,325651834.0,3757.0,25.1189,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
654,596400,1,5,,103166269,6758,Unspecified,,,,,Selective toxicity against mouse C38 cells assessed as differential zone units at 0.23 ug/mL by disk diffusion soft agar colony formation assay relative to mouse L1210 cells,Other,21452840.0,
655,596403,2,3,,103166269,6758,Unspecified,,,,,Cytotoxicity against human HCT116 cells measured per disk after 5 days by hemocytometer counting,Other,21452840.0,
656,602332,1,1,,90340839,6758,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
657,602332,1,1,,104171353,6758,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
658,602332,1,1,,124883112,6758,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
659,610727,1,3,,103166269,6758,Unspecified,,,,,Inhibition of Rhodobacter capsulatus NADH-ubiquinone oxidoreductase using Q0 as substrate,Other,20409720.0,
660,610728,1,3,,103166269,6758,Unspecified,,,,,Inhibition of Rhodobacter capsulatus NADH-ubiquinone oxidoreductase using AzQ0 as substrate,Other,20409720.0,
661,610729,1,3,,103166269,6758,Unspecified,,,,,Inhibition of Rhodobacter capsulatus NADH-ubiquinone oxidoreductase using Q1 as substrate,Other,20409720.0,
662,610730,1,3,,103166269,6758,Unspecified,,,,,Inhibition of Rhodobacter capsulatus NADH-ubiquinone oxidoreductase using AzQ1 as substrate,Other,20409720.0,
663,610764,1,3,,103166269,6758,Unspecified,,,,,Inhibition of Rhodobacter capsulatus NADH-ubiquinone oxidoreductase using DMB as substrate,Other,20409720.0,
664,610765,1,3,,103166269,6758,Unspecified,,,,,Inhibition of Rhodobacter capsulatus NADH-ubiquinone oxidoreductase using DAzB as substrate,Other,20409720.0,
665,612539,5,1,,103166269,6758,Unspecified,,,78.0,IC50,Cytotoxicity against human HeLa cells after 24 hrs by luminometry,Confirmatory,21741837.0,
666,624030,1,2,,104171353,6758,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
667,624031,1,2,,104171353,6758,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
668,624032,1,2,,104171353,6758,Inconclusive,8393992.0,24660.0,0.0573,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
669,624044,1,2,,104171353,6758,Inconclusive,8393992.0,24660.0,0.0794,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
670,624146,1,1,,90340839,6758,Active,71051501.0,2744.0,11.2202,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
671,624147,1,1,,90340839,6758,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
672,624148,1,2,,90340839,6758,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
673,624149,1,1,,90340839,6758,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
674,624170,1,1,,104171353,6758,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
675,624172,1,1,,104171353,6758,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
676,624173,1,3,,104171353,6758,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
677,624296,1,1,,26753652,6758,Active,7705682.0,51053.0,3.9327,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
678,624296,1,1,,104171353,6758,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
679,624297,1,1,,26753652,6758,Inconclusive,7705682.0,51053.0,1.4125,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
680,624297,1,1,,104171353,6758,Inconclusive,7705682.0,51053.0,14.9631,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
681,624455,1,1,,90340839,6758,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
682,625144,5,5,,103166269,6758,Unspecified,239977155.0,,,IC50,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),Confirmatory,,
683,625145,4,7,,103166269,6758,Unspecified,20138087.0,10800.0,,IC50,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),Confirmatory,,
684,625146,5,5,,103166269,6758,Unspecified,126397.0,100009114.0,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),Confirmatory,,
685,625147,4,7,,103166269,6758,Unspecified,395398606.0,4159.0,,IC50,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
686,625148,4,7,,103166269,6758,Unspecified,60392672.0,4160.0,,IC50,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
687,625149,4,7,,103166269,6758,Unspecified,729996.0,4161.0,,IC50,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
688,625150,5,5,,103166269,6758,Unspecified,113978.0,4128.0,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),Confirmatory,,
689,625151,4,7,,103166269,6758,Unspecified,113118.0,1128.0,,IC50,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
690,625152,4,7,,103166269,6758,Unspecified,113122.0,1129.0,,IC50,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
691,625153,4,7,,103166269,6758,Unspecified,113125.0,1131.0,,IC50,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
692,625154,4,7,,103166269,6758,Unspecified,23503039.0,1132.0,,IC50,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
693,625155,4,7,,103166269,6758,Unspecified,543761.0,1133.0,,IC50,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
694,625156,1,9,,103166269,6758,Unspecified,128997.0,4886.0,,,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),Other,,
695,625157,6,2,,103166269,6758,Unspecified,1352610.0,4887.0,,IC50,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),Confirmatory,,
696,625158,3,4,,103166269,6758,Unspecified,,,,IC50,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),Confirmatory,,
697,625159,5,5,,103166269,6758,Unspecified,266646.0,24598.0,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",Confirmatory,,
698,625160,1,9,,103166269,6758,Unspecified,266649.0,18126.0,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",Other,,
699,625161,4,7,,103166269,6758,Unspecified,311033488.0,4985.0,,IC50,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",Confirmatory,,
700,625162,4,7,,103166269,6758,Unspecified,116242691.0,4986.0,,IC50,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
701,625163,4,7,,103166269,6758,Unspecified,2851402.0,4988.0,,IC50,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
702,625164,1,6,,103166269,6758,Unspecified,,,,,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),Other,,
703,625165,3,4,,103166269,6758,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
704,625166,3,4,,103166269,6758,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
705,625167,5,5,,103166269,6758,Unspecified,317373261.0,8654.0,,IC50,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),Confirmatory,,
706,625168,4,7,,103166269,6758,Unspecified,129557.0,5724.0,,IC50,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),Confirmatory,,
707,625169,1,6,,103166269,6758,Unspecified,,,,,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),Other,,
708,625170,3,4,,103166269,6758,Unspecified,,,,IC50,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),Confirmatory,,
709,625171,4,7,,103166269,6758,Unspecified,7531135.0,3757.0,,IC50,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Confirmatory,,
710,625172,4,7,,103166269,6758,Unspecified,75071465.0,,,IC50,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),Confirmatory,,
711,625173,5,5,,103166269,6758,Unspecified,2822103.0,100009274.0,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",Confirmatory,,
712,625174,5,5,,103166269,6758,Unspecified,266321.0,834.0,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",Confirmatory,,
713,625175,5,5,,103166269,6758,Unspecified,115725.0,1511.0,,IC50,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",Confirmatory,,
714,625176,1,9,,103166269,6758,Unspecified,119292.0,1991.0,,,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",Other,,
715,625177,5,5,,103166269,6758,Unspecified,116852.0,4312.0,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
716,625178,5,5,,103166269,6758,Unspecified,269849668.0,4318.0,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
717,625179,1,9,,103166269,6758,Unspecified,317373571.0,5578.0,,,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),Other,,
718,625180,5,5,,103166269,6758,Unspecified,232066.0,5595.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
719,625181,5,5,,103166269,6758,Unspecified,119554.0,5594.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
720,625182,5,5,,103166269,6758,Unspecified,2499600.0,1432.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
721,625183,5,5,,103166269,6758,Unspecified,1352673.0,5530.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",Confirmatory,,
722,625184,5,5,,103166269,6758,Unspecified,2811086.0,1956.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
723,625185,5,5,,103166269,6758,Unspecified,125370.0,2534.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
724,625186,5,5,,103166269,6758,Unspecified,119533.0,2064.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
725,625187,5,5,,103166269,6758,Unspecified,125474.0,3932.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
726,625188,1,9,,103166269,6758,Unspecified,33112650.0,5788.0,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",Other,,
727,625189,1,7,,103166269,6758,Unspecified,,,,,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",Other,,
728,625190,4,5,,103166269,6758,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),Confirmatory,,
729,625191,4,7,,103166269,6758,Unspecified,112815.0,25075.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
730,625192,4,7,,103166269,6758,Unspecified,543727.0,3356.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),Confirmatory,,
731,625193,5,5,,103166269,6758,Unspecified,113037.0,43.0,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Confirmatory,,
732,625194,4,7,,103166269,6758,Unspecified,231473.0,134.0,,IC50,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),Confirmatory,,
733,625195,4,7,,103166269,6758,Unspecified,543740.0,135.0,,IC50,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),Confirmatory,,
734,625196,5,6,,103166269,6758,Unspecified,803374855.0,140.0,,IC50,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),Confirmatory,,
735,625197,3,4,,103166269,6758,Unspecified,,,,IC50,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),Confirmatory,,
736,625198,4,7,,103166269,6758,Unspecified,1168247.0,29412.0,,IC50,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
737,625199,4,7,,103166269,6758,Unspecified,543734.0,24173.0,,IC50,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
738,625200,4,7,,103166269,6758,Unspecified,1168243.0,146.0,,IC50,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
739,625201,4,7,,103166269,6758,Unspecified,1351829.0,150.0,,IC50,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Confirmatory,,
740,625202,4,7,,103166269,6758,Unspecified,613504690.0,151.0,,IC50,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),Confirmatory,,
741,625203,4,7,,103166269,6758,Unspecified,20141211.0,152.0,,IC50,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),Confirmatory,,
742,625204,4,7,,103166269,6758,Unspecified,48429211.0,153.0,,IC50,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
743,625205,4,7,,103166269,6758,Unspecified,296439450.0,154.0,,IC50,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),Confirmatory,,
744,625206,4,7,,103166269,6758,Unspecified,461604.0,155.0,,IC50,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
745,625207,4,7,,103166269,6758,Unspecified,128616.0,6530.0,,IC50,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
746,625208,5,5,,103166269,6758,Unspecified,1168407.0,24192.0,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),Confirmatory,,
747,625209,4,7,,103166269,6758,Unspecified,1703214.0,186.0,,IC50,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),Confirmatory,,
748,625210,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",Confirmatory,,
749,625211,1,6,,103166269,6758,Unspecified,,,,,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),Other,,
750,625212,3,4,,103166269,6758,Unspecified,,,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),Confirmatory,,
751,625213,4,7,,103166269,6758,Unspecified,2506481.0,624.0,,IC50,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),Confirmatory,,
752,625214,1,9,,103166269,6758,Unspecified,550544247.0,799.0,,,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),Other,,
753,625215,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",Confirmatory,,
754,625216,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",Confirmatory,,
755,625217,4,7,,103166269,6758,Unspecified,1168220.0,3357.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
756,625218,4,7,,103166269,6758,Unspecified,112816.0,3358.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),Confirmatory,,
757,625219,3,4,,103166269,6758,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),Confirmatory,,
758,625220,4,7,,103166269,6758,Unspecified,6224984.0,100135548.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),Confirmatory,,
759,625221,4,7,,103166269,6758,Active,1703010.0,3362.0,0.87,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
760,625222,4,7,,103166269,6758,Unspecified,400630.0,6532.0,,IC50,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",Confirmatory,,
761,625223,4,7,,103166269,6758,Unspecified,74752153.0,10280.0,,IC50,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),Confirmatory,,
762,625224,3,4,,103166269,6758,Unspecified,,,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),Confirmatory,,
763,625225,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",Confirmatory,,
764,625226,4,7,,103166269,6758,Unspecified,128359.0,6869.0,,IC50,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),Confirmatory,,
765,625227,4,7,,103166269,6758,Unspecified,229462950.0,6865.0,,IC50,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),Confirmatory,,
766,625228,4,7,,103166269,6758,Unspecified,113832.0,24208.0,,IC50,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),Confirmatory,,
767,625229,5,5,,103166269,6758,Unspecified,254763392.0,6916.0,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),Confirmatory,,
768,625230,1,6,,103166269,6758,Unspecified,,,,,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",Other,,
769,625231,4,7,,103166269,6758,Unspecified,143811474.0,2321.0,,IC50,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),Confirmatory,,
770,625232,1,9,,103166269,6758,Unspecified,418253.0,7433.0,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),Other,,
771,625233,4,7,,103166269,6758,Unspecified,586197.0,552.0,,IC50,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),Confirmatory,,
772,625234,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",Confirmatory,,
773,625235,4,7,,103166269,6758,Unspecified,115562.0,1268.0,,IC50,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),Confirmatory,,
774,625236,5,5,,103166269,6758,Unspecified,115456.0,760.0,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),Confirmatory,,
775,625237,4,7,,103166269,6758,Unspecified,1168965.0,729230.0,,IC50,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),Confirmatory,,
776,625238,4,7,,103166269,6758,Unspecified,1705894.0,1233.0,,IC50,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),Confirmatory,,
777,625239,4,7,,103166269,6758,Unspecified,1705896.0,1234.0,,IC50,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),Confirmatory,,
778,625240,1,9,,103166269,6758,Unspecified,108936015.0,3577.0,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),Other,,
779,625241,4,7,,103166269,6758,Unspecified,1352454.0,3579.0,,IC50,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),Confirmatory,,
780,625242,4,7,,103166269,6758,Unspecified,416772.0,886.0,,IC50,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",Confirmatory,,
781,625243,5,5,,103166269,6758,Unspecified,317373262.0,5742.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
782,625244,5,5,,103166269,6758,Unspecified,3915797.0,5743.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
783,625245,5,5,,103166269,6758,Unspecified,117144.0,1544.0,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
784,625246,1,9,,103166269,6758,Unspecified,308153612.0,1548.0,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Other,,
785,625247,5,5,,103166269,6758,Active,60416369.0,1557.0,3.6486,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
786,625248,5,5,,103166269,6758,Unspecified,6686268.0,1559.0,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
787,625249,5,5,,103166269,6758,Unspecified,84028191.0,1565.0,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
788,625250,5,5,,103166269,6758,Unspecified,117250.0,1571.0,,IC50,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
789,625251,5,5,,103166269,6758,Unspecified,116241312.0,1576.0,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",Confirmatory,,
790,625252,4,7,,103166269,6758,Unspecified,118228.0,1812.0,,IC50,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),Confirmatory,,
791,625253,4,7,,103166269,6758,Unspecified,118206.0,1813.0,,IC50,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
792,625254,4,7,,103166269,6758,Unspecified,1169206.0,1814.0,,IC50,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
793,625255,4,7,,103166269,6758,Unspecified,1345939.0,1815.0,,IC50,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
794,625256,4,7,,103166269,6758,Unspecified,266667.0,6531.0,,IC50,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
795,625257,4,7,,103166269,6758,Unspecified,119606.0,1909.0,,IC50,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),Confirmatory,,
796,625258,4,7,,103166269,6758,Unspecified,544257.0,2099.0,,IC50,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
797,625259,4,7,,103166269,6758,Unspecified,6166154.0,2100.0,,IC50,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
798,625260,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",Confirmatory,,
799,625261,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",Confirmatory,,
800,625262,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",Confirmatory,,
801,625263,4,7,,103166269,6758,Unspecified,121069.0,2908.0,,IC50,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),Confirmatory,,
802,625264,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",Confirmatory,,
803,625265,1,6,,103166269,6758,Unspecified,,,,,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",Other,,
804,625266,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",Confirmatory,,
805,625267,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",Confirmatory,,
806,625268,4,2,,103166269,6758,Unspecified,121579.0,24397.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
807,625268,4,2,,103166269,6758,Unspecified,121580.0,114516.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
808,625268,4,2,,103166269,6758,Unspecified,121604.0,25456.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
809,625268,4,2,,103166269,6758,Unspecified,12230887.0,25674.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
810,625269,4,7,,103166269,6758,Unspecified,547645.0,3269.0,,IC50,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",Confirmatory,,
811,625270,4,7,,103166269,6758,Unspecified,123120.0,3274.0,,IC50,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),Confirmatory,,
812,625271,5,5,,103166269,6758,Unspecified,123343.0,3156.0,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),Confirmatory,,
813,625272,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",Confirmatory,,
814,625273,4,6,,103166269,6758,Unspecified,124531.0,24954.0,,IC50,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),Confirmatory,,
815,625274,1,6,,103166269,6758,Unspecified,,,,,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),Other,,
816,625275,3,4,,103166269,6758,Unspecified,,,,IC50,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",Confirmatory,,
817,627227,1,4,,103166269,6758,Unspecified,,,,,Inhibition of cellular respiration in human MDA-MB-231 cells assessed as rate of oxygen consumption,Other,21875114.0,
818,627228,1,4,,103166269,6758,Active,,,,,Inhibition of cellular respiration in human T47D cells assessed as rate of oxygen consumption at 0.001 to 0.1 uM,Other,21875114.0,
819,627230,1,4,,103166269,6758,Unspecified,,,,,Reduction in ATP level in human MDA-MB-231 cells after 72 hrs by HPLC-UV analysis,Other,21875114.0,
820,627231,1,4,,103166269,6758,Unspecified,,,,,Reduction in ATP level in human T47D cells after 72 hrs by HPLC-UV analysis,Other,21875114.0,
821,627232,1,4,,103166269,6758,Active,,,,,Reduction in ATP level in human T47D cells after 48 hrs by HPLC-UV analysis,Other,21875114.0,
822,627233,1,4,,103166269,6758,Active,,,,,Reduction in ATP level in human T47D cells at 0.01 to 0.1 uM after 72 hrs by HPLC-UV analysis,Other,21875114.0,
823,627235,1,4,,103166269,6758,Unspecified,,,,,Antiproliferative activity against human T47D cells assessed as cell viability at 0.01 to 0.1 uM after 72 hrs by SRB assay,Other,21875114.0,
824,627237,1,9,,103166269,6758,Inactive,1169735.0,2475.0,,,Inhibition of mTOR-mediated 4E-BP1 phosphorylation on Thr 37/46 in human T47D cells at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
825,627239,1,9,,103166269,6758,Inactive,1169735.0,2475.0,,,Inhibition of mTORC1-mediated rpS6 phosphorylation on Ser 235/236 in human T47D cells at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
826,627241,1,9,,103166269,6758,Inactive,1169735.0,2475.0,,,Inhibition of mTORC1-mediated eIF4E phosphorylation on Ser 209 in human T47D cells at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
827,627295,1,9,,103166269,6758,Active,1169735.0,2475.0,,,Inhibition of mTOR in human T47D cells assessed as eIF2alpha hyperphosphorylation on Ser 51 at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
828,627297,1,9,,103166269,6758,Active,1169735.0,2475.0,,,Inhibition of mTOR in human T47D cells assessed as eEF2 hyperphosphorylation on Ser 56 at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
829,627299,1,9,,103166269,6758,Inactive,1169735.0,2475.0,,,Inhibition of mTOR-mediated 4E-BP1 phosphorylation on Thr 37/46 in human MDA-MB-231 cells at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
830,627301,1,9,,103166269,6758,Inactive,1169735.0,2475.0,,,Inhibition of mTOR-mediated rpS6 phosphorylation on Ser 235/236 in human MDA-MB-231 cells at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
831,627303,1,9,,103166269,6758,Inactive,1169735.0,2475.0,,,Inhibition of mTOR-mediated eIF4E phosphorylation on Ser 209 in human MDA-MB-231 cells at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
832,627305,1,9,,103166269,6758,Active,1169735.0,2475.0,,,Inhibition of mTOR in human MDA-MB-231 cells assessed as eIF2alpha hyperphosphorylation on Ser 51 at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
833,627307,1,9,,103166269,6758,Active,1169735.0,2475.0,,,Inhibition of mTOR in human MDA-MB-231 cells assessed as eEF2 hyperphosphorylation on Ser 56 at 0.1 to 1 uM after 30 mins by Western blotting,Other,21875114.0,
834,627311,1,4,,103166269,6758,Active,,,,,Reduction in ATP level in human MDA-MB-231 cells at 0.01 to 0.1 uM after 48 hrs by HPLC-UV analysis,Other,21875114.0,
835,640432,3,2,,103166269,6758,Unspecified,,,,,Cytotoxicity against human A549 cells by SRB assay,Other,22204911.0,
836,640433,3,2,,103166269,6758,Unspecified,,,,,Cytotoxicity against human DU145 cells by SRB assay,Other,22204911.0,
837,640434,3,2,,103166269,6758,Unspecified,,,,,Cytotoxicity against human KB cells by SRB assay,Other,22204911.0,
838,640435,3,3,,103166269,6758,Unspecified,,,,,Cytotoxicity against human KBVIN cells by SRB assay,Other,22204911.0,
839,651631,4,1,,144204370,6758,Active,269849759.0,7157.0,0.3349,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
840,651631,4,1,,144209102,6758,Active,269849759.0,7157.0,0.1556,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
841,651631,4,1,,144211012,6758,Active,269849759.0,7157.0,0.2731,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
842,651632,4,1,,144204370,6758,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
843,651632,4,1,,144209102,6758,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
844,651632,4,1,,144211012,6758,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
845,651633,4,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
846,651633,4,1,,144209102,6758,Inactive,,,15.5585,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
847,651633,4,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
848,651634,4,1,,144204370,6758,Inconclusive,,,1.496,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
849,651634,4,1,,144209102,6758,Active,,,0.1387,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
850,651634,4,1,,144211012,6758,Active,,,0.4856,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
851,651635,1,3,,90340839,6758,Inconclusive,171543895.0,6311.0,22.3872,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
852,651741,1,1,,144204370,6758,Inconclusive,20149576.0,4780.0,30.6379,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
853,651743,1,1,,26753652,6758,Inconclusive,269849759.0,7157.0,0.1259,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
854,651749,1,1,,26753652,6758,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
855,651751,1,1,,26753652,6758,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
856,651777,1,1,,26753652,6758,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
857,651778,1,1,,26753652,6758,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
858,651838,1,1,,26753652,6758,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
859,651838,1,1,1.0,26753652,6758,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
860,651838,1,1,2.0,26753652,6758,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
861,651838,1,1,3.0,26753652,6758,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
862,651838,1,1,4.0,26753652,6758,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
863,651838,1,1,5.0,26753652,6758,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
864,651838,1,1,6.0,26753652,6758,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
865,651838,1,1,7.0,26753652,6758,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
866,651838,1,1,8.0,26753652,6758,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
867,652048,1,2,,144204370,6758,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
868,652051,1,1,,144204370,6758,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
869,652106,1,1,,90340839,6758,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
870,686978,1,1,,124883112,6758,Active,79154014.0,55775.0,0.1496,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
871,686978,1,1,,144204370,6758,Active,79154014.0,55775.0,0.2371,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
872,686979,1,1,,124883112,6758,Active,79154014.0,55775.0,0.1884,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
873,686979,1,1,,144204370,6758,Active,79154014.0,55775.0,0.2371,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
874,687035,1,1,,163565066,6758,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening assay of LOPAC1280 to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
875,687037,1,3,,163565066,6758,Inactive,,,,,Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in LOPAC1280: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-DNA-NS3h complex,Screening,,
876,697852,1,7,,103166269,6758,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
877,697853,1,7,,103166269,6758,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
878,718657,1,2,,103166269,6758,Unspecified,,,,,Effect on lactate production in human MDA-MB-231 cells at 0.1 uM measured per ug of cellular protein after 48 hrs by enzyme based assay (Rvb = 40.5 +/- 6 nmol/ug of cellular protein),Other,23245650.0,
879,718662,1,2,,103166269,6758,Unspecified,,,,,Effect on lactate production in human MDA-MB-231 cells at 0.1 uM measured per ug of cellular protein after 24 hrs by enzyme based assay (Rvb = 23.6 +/- 2 nmol/ug of cellular protein),Other,23245650.0,
880,718667,1,2,,103166269,6758,Unspecified,,,,,Increase in cellular glucose consumption in human MDA-MB-231 cells at 0.1 uM measured per ug of cellular protein after 48 hrs by enzyme based assay (Rvb = 43 +/- 8.4 nmol/ug of cellular protein),Other,23245650.0,
881,718672,1,2,,103166269,6758,Unspecified,,,,,Increase in cellular glucose consumption in human MDA-MB-231 cells at 0.1 uM measured per ug of cellular protein after 24 hrs by enzyme based assay (Rvb = 17.2 +/- 2 nmol/ug of cellular protein),Other,23245650.0,
882,718681,1,2,,103166269,6758,Unspecified,,,,,Inhibition of cell viability of human MDA-MB-231 cells at 0.1 uM after 48 hrs by sulforhodamine B method,Other,23245650.0,
883,720516,2,1,,144204370,6758,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
884,720516,2,1,,144209102,6758,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
885,720516,2,1,,144211012,6758,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
886,720532,1,1,,124883112,6758,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
887,720532,1,1,,144204370,6758,Inconclusive,420597.0,,31.6228,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
888,720533,1,1,,124883112,6758,Inconclusive,,,5.0119,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
889,720533,1,1,,144204370,6758,Inconclusive,,,39.8107,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
890,720538,1,2,,90340839,6758,Inactive,220983390.0,410.0,,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
891,720552,2,1,,144204370,6758,Active,269849759.0,7157.0,0.42163199999999995,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
892,720552,2,1,,144209102,6758,Active,269849759.0,7157.0,0.203533,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
893,720552,2,1,,144211012,6758,Active,269849759.0,7157.0,0.243365,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
894,720559,1,2,,90340839,6758,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
895,720572,1,2,,90340839,6758,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
896,720573,1,2,,90340839,6758,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
897,720634,2,1,,144204370,6758,Active,,,11.8832,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
898,720634,2,1,,144209102,6758,Active,,,31.0433,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
899,720634,2,1,,144211012,6758,Active,,,12.1972,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
900,720635,2,1,,144204370,6758,Active,,,14.9601,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
901,720635,2,1,,144209102,6758,Active,,,31.0433,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
902,720635,2,1,,144211012,6758,Active,,,4.8558,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
903,720636,1,1,,144204370,6758,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
904,720637,2,1,,144204370,6758,Inconclusive,,,16.7855,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
905,720637,2,1,,144209102,6758,Inconclusive,,,34.8312,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
906,720637,2,1,,144211012,6758,Inconclusive,,,8.97274,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
907,720653,1,1,,26753652,6758,Inconclusive,,,10.0,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
908,720659,1,1,,26753652,6758,Inconclusive,325495557.0,8856.0,15.8489,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
909,720674,2,2,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
910,720674,2,2,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
911,720674,2,2,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
912,720675,2,2,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
913,720675,2,2,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
914,720675,2,2,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
915,720678,2,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
916,720678,2,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
917,720678,2,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
918,720679,2,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
919,720679,2,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
920,720679,2,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
921,720680,2,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
922,720680,2,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
923,720680,2,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
924,720681,2,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
925,720681,2,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
926,720681,2,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
927,720682,2,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
928,720682,2,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
929,720682,2,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
930,720683,2,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
931,720683,2,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
932,720683,2,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
933,720684,2,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
934,720684,2,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
935,720684,2,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
936,720685,2,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
937,720685,2,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
938,720685,2,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
939,720686,2,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
940,720686,2,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
941,720686,2,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
942,720687,2,2,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
943,720687,2,2,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
944,720687,2,2,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
945,720691,4,1,,144204370,6758,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
946,720691,4,1,,144209102,6758,Inactive,311348376.0,2908.0,55.6812,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
947,720691,4,1,,144211012,6758,Inconclusive,311348376.0,2908.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
948,720692,3,1,,144204370,6758,Inconclusive,311348376.0,2908.0,1.8996,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
949,720692,3,1,,144209102,6758,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
950,720692,3,1,,144211012,6758,Inconclusive,311348376.0,2908.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
951,720693,3,1,,144204370,6758,Inconclusive,,,1.0682,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
952,720693,3,1,,144209102,6758,Inconclusive,,,62.4754,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
953,720693,3,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
954,720719,2,1,,144204370,6758,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
955,720719,2,1,,144209102,6758,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
956,720719,2,1,,144211012,6758,Inconclusive,311348376.0,2908.0,33.3603,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
957,720725,2,1,,144204370,6758,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
958,720725,2,1,,144209102,6758,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
959,720725,2,1,,144211012,6758,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
960,735970,1,3,,103166269,6758,Unspecified,,,,,Cytotoxicity against mouse 3T3L1 cells assessed as cell viability at 0.02 to 20 uM by MTT assay,Other,23317572.0,
961,735972,4,2,,103166269,6758,Unspecified,6686288.0,100157809.0,500.0,IC50,Inhibition of pig pancreatic lipase assessed as hydrolysis of p-nitrophenylbutyrate to p-nitrophenol,Confirmatory,23317572.0,
962,739256,1,2,,103166269,6758,Inactive,,,,,Inhibition of mitochondrial ETC complex 4 in human digitonin-permeabalized T47D cells assessed as inhibition of ascorbate/TMPD-initiated respiration at 0.01 uM after 2 hrs by Clarke-type electrode analysis in presence of antimycin A,Other,23434131.0,
963,739258,1,2,,103166269,6758,Unspecified,,,,,Inhibition of mitochondrial ETC complex 2 in human digitonin-permeabalized T47D cells assessed as inhibition of succinate-initiated respiration at 0.01 uM after 2 hrs by Clarke-type electrode analysis,Other,23434131.0,
964,739259,1,2,,103166269,6758,Unspecified,,,,,Inhibition of mitochondrial ETC complex 1 in human digitonin-permeabalized T47D cells assessed as inhibition of malate/pyruvate-initiated respiration at 0.01 uM after 2 hrs by Clarke-type electrode analysis,Other,23434131.0,
965,739262,1,2,,103166269,6758,Unspecified,,,,,Inhibition of mitochondrial ETC complex 1 in human T47D cells assessed as inhibition of oxygen consumption at 0.01 uM after 2 hrs by Clarke-type electrode analysis,Other,23434131.0,
966,739263,1,2,,103166269,6758,Unspecified,,,,,Inhibition of mitochondrial ETC complex 1 in human T47D cells assessed as inhibition of oxygen consumption at 0.01 uM after 10 mins by Clarke-type electrode analysis,Other,23434131.0,
967,743012,3,1,,144204370,6758,Active,,,0.0596,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
968,743012,3,1,,144209102,6758,Active,,,0.0196,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
969,743012,3,1,,144211012,6758,Active,,,0.0086,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
970,743014,3,1,,144204370,6758,Active,,,0.1188,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
971,743014,3,1,,144209102,6758,Active,,,0.011000000000000001,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
972,743014,3,1,,144211012,6758,Active,,,0.0086,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
973,743015,3,1,,144204370,6758,Active,,,0.075,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
974,743015,3,1,,144209102,6758,Active,,,0.0098,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
975,743015,3,1,,144211012,6758,Active,,,0.0086,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
976,743033,3,1,,144204370,6758,Inconclusive,,,0.3011,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
977,743033,3,1,,144209102,6758,Active,,,0.0625,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
978,743033,3,1,,144211012,6758,Active,,,0.0389,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
979,743035,2,1,,144204370,6758,Active,124375976.0,367.0,0.7562,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
980,743035,2,1,,144209102,6758,Active,124375976.0,367.0,0.2791,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
981,743035,2,1,,144211012,6758,Inconclusive,124375976.0,367.0,0.0078,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
982,743036,2,1,,144204370,6758,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
983,743036,2,1,,144209102,6758,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
984,743036,2,1,,144211012,6758,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
985,743040,3,1,,144204370,6758,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
986,743040,3,1,,144209102,6758,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
987,743040,3,1,,144211012,6758,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
988,743041,3,1,,144204370,6758,Active,,,0.3929,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
989,743041,3,1,,144209102,6758,Active,,,0.0391,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
990,743041,3,1,,144211012,6758,Active,,,0.0306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
991,743042,3,1,,144204370,6758,Active,124375976.0,367.0,0.1883,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
992,743042,3,1,,144209102,6758,Active,124375976.0,367.0,0.0247,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
993,743042,3,1,,144211012,6758,Active,124375976.0,367.0,0.0097,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
994,743053,2,1,,144204370,6758,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
995,743053,2,1,,144209102,6758,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
996,743053,2,1,,144211012,6758,Inconclusive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
997,743054,2,1,,144204370,6758,Inconclusive,124375976.0,367.0,0.188336,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
998,743054,2,1,,144209102,6758,Inconclusive,124375976.0,367.0,0.029874599999999998,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
999,743054,2,1,,144211012,6758,Inconclusive,124375976.0,367.0,0.026277999999999996,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1000,743063,2,1,,144204370,6758,Inconclusive,124375976.0,367.0,0.989298,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1001,743063,2,1,,144209102,6758,Inconclusive,124375976.0,367.0,0.221671,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1002,743063,2,1,,144211012,6758,Inconclusive,124375976.0,367.0,0.194938,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1003,743064,3,1,,144204370,6758,Active,,,0.8413,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1004,743064,3,1,,144209102,6758,Active,,,8.7492,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1005,743064,3,1,,144211012,6758,Active,,,4.8558,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1006,743065,3,1,,144204370,6758,Active,399498506.0,24831.0,0.2371,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1007,743065,3,1,,144209102,6758,Active,399498506.0,24831.0,0.0348,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1008,743065,3,1,,144211012,6758,Active,399498506.0,24831.0,0.0611,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1009,743066,3,1,,144204370,6758,Inconclusive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1010,743066,3,1,,144209102,6758,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1011,743066,3,1,,144211012,6758,Inconclusive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1012,743067,2,1,,144204370,6758,Active,399498506.0,24831.0,0.211317,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1013,743067,2,1,,144209102,6758,Active,399498506.0,24831.0,0.0256233,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1014,743067,2,1,,144211012,6758,Active,399498506.0,24831.0,0.0504574,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1015,743069,2,1,,144204370,6758,Inconclusive,348019627.0,2099.0,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1016,743069,2,1,,144209102,6758,Inconclusive,348019627.0,2099.0,39.4193,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1017,743069,2,1,,144211012,6758,Active,348019627.0,2099.0,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1018,743074,2,1,,144204370,6758,Active,,,0.0674,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1019,743074,2,1,,144209102,6758,Active,,,0.0442,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1020,743074,2,1,,144211012,6758,Inconclusive,,,0.0275,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1021,743075,2,1,,144204370,6758,Inactive,348019627.0,2099.0,0.674,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1022,743075,2,1,,144209102,6758,Inconclusive,348019627.0,2099.0,0.0442,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1023,743075,2,1,,144211012,6758,Inconclusive,348019627.0,2099.0,0.0275,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1024,743077,2,1,,144204370,6758,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1025,743077,2,1,,144209102,6758,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1026,743077,2,1,,144211012,6758,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1027,743078,2,1,,144204370,6758,Inconclusive,348019627.0,2099.0,24.85,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1028,743078,2,1,,144209102,6758,Inconclusive,348019627.0,2099.0,52.5665,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1029,743078,2,1,,144211012,6758,Active,348019627.0,2099.0,40.4169,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1030,743079,3,1,,144204370,6758,Inconclusive,348019627.0,2099.0,0.0944,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1031,743079,3,1,,144209102,6758,Inconclusive,348019627.0,2099.0,0.0277,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1032,743079,3,1,,144211012,6758,Inconclusive,348019627.0,2099.0,0.0243,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1033,743080,3,1,,144204370,6758,Active,348019627.0,2099.0,0.1496,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1034,743080,3,1,,144209102,6758,Active,348019627.0,2099.0,0.0391,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1035,743080,3,1,,144211012,6758,Active,348019627.0,2099.0,0.0154,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1036,743081,3,1,,144204370,6758,Inconclusive,,,1.6785,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1037,743081,3,1,,144209102,6758,Active,,,7.7977,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1038,743081,3,1,,144211012,6758,Active,,,38.5708,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1039,743083,3,1,,144204370,6758,Active,119597822.0,1588.0,14.9601,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1040,743083,3,1,,144209102,6758,Active,119597822.0,1588.0,34.8312,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1041,743083,3,1,,144211012,6758,Active,119597822.0,1588.0,34.3762,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1042,743084,3,1,,144204370,6758,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1043,743084,3,1,,144209102,6758,Active,,,34.8312,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1044,743084,3,1,,144211012,6758,Active,,,34.3762,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1045,743085,3,1,,144204370,6758,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1046,743085,3,1,,144209102,6758,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1047,743085,3,1,,144211012,6758,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1048,743086,3,1,,144204370,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1049,743086,3,1,,144209102,6758,Active,,,39.0813,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1050,743086,3,1,,144211012,6758,Active,,,21.6899,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1051,743091,2,1,,144204370,6758,Active,348019627.0,2099.0,0.143968,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1052,743091,2,1,,144209102,6758,Active,348019627.0,2099.0,0.0310433,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1053,743091,2,1,,144211012,6758,Active,348019627.0,2099.0,0.030637900000000003,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1054,743094,3,1,,144204370,6758,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1055,743094,3,1,,144209102,6758,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1056,743094,3,1,,144211012,6758,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1057,743122,2,1,,144204370,6758,Inconclusive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1058,743122,2,1,,144209102,6758,Inconclusive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1059,743122,2,1,,144211012,6758,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1060,743139,2,1,,144204370,6758,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1061,743139,2,1,,144209102,6758,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1062,743139,2,1,,144211012,6758,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1063,743140,2,1,,144204370,6758,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1064,743140,2,1,,144209102,6758,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1065,743140,2,1,,144211012,6758,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1066,743191,3,1,,144209102,6758,Inconclusive,216409692.0,5468.0,5.5681,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1067,743191,3,1,,144211012,6758,Inconclusive,216409692.0,5468.0,15.4845,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1068,743191,3,1,,170466816,6758,Active,216409692.0,5468.0,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1069,743194,3,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1070,743194,3,1,,144211012,6758,Inconclusive,,,10.9622,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1071,743194,3,1,,170466816,6758,Inconclusive,,,29.846999999999998,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1072,743199,2,1,,144209102,6758,Active,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1073,743199,2,1,,144211012,6758,Active,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1074,743199,2,1,,170466816,6758,Active,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1075,743202,4,1,,144209102,6758,Inconclusive,20149576.0,4780.0,12.3586,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1076,743202,4,1,,144211012,6758,Active,20149576.0,4780.0,0.0077,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1077,743202,4,1,,170466816,6758,Inconclusive,20149576.0,4780.0,13.3322,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1078,743203,3,1,,144209102,6758,Active,,,15.5585,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1079,743203,3,1,,144211012,6758,Active,,,3.8571,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1080,743203,3,1,,170466816,6758,Active,,,3.7575,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1081,743205,1,1,,90340839,6758,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1082,743205,1,1,,90340839,6758,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1083,743206,1,1,,90340839,6758,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1084,743206,1,1,,90340839,6758,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1085,743207,1,1,,90340839,6758,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1086,743207,1,1,,90340839,6758,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1087,743209,3,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1088,743209,3,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1089,743209,3,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1090,743210,4,1,,144209102,6758,Inconclusive,4504517.0,3315.0,55.6812,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1091,743210,4,1,,144211012,6758,Inconclusive,4504517.0,3315.0,38.8952,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1092,743210,4,1,,170466816,6758,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1093,743211,3,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1094,743211,3,1,,144211012,6758,Inconclusive,,,0.0245,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1095,743211,3,1,,170466816,6758,Inconclusive,,,3.3489,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1096,743212,3,1,,144209102,6758,Inconclusive,216409690.0,5467.0,39.4193,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1097,743212,3,1,,144211012,6758,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1098,743212,3,1,,170466816,6758,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1099,743213,3,1,,144209102,6758,Inconclusive,,,22.1671,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1100,743213,3,1,,144211012,6758,Inconclusive,,,2.7536,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1101,743213,3,1,,170466816,6758,Inconclusive,,,13.3322,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1102,743215,3,1,,144209102,6758,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1103,743215,3,1,,144211012,6758,Active,216409690.0,5467.0,4.8966,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1104,743215,3,1,,170466816,6758,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1105,743217,3,1,,144209102,6758,Inconclusive,325495553.0,9971.0,49.626000000000005,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1106,743217,3,1,,144211012,6758,Inconclusive,325495553.0,9971.0,15.4845,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1107,743217,3,1,,170466816,6758,Active,325495553.0,9971.0,0.7497,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1108,743218,3,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1109,743218,3,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1110,743218,3,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1111,743219,3,1,,144209102,6758,Active,20149576.0,4780.0,0.020353299999999998,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1112,743219,3,1,,144211012,6758,Active,20149576.0,4780.0,0.017903,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1113,743219,3,1,,170466816,6758,Active,20149576.0,4780.0,0.0455233,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1114,743220,3,1,,144209102,6758,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1115,743220,3,1,,144211012,6758,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1116,743220,3,1,,170466816,6758,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1117,743221,3,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1118,743221,3,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1119,743221,3,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1120,743222,3,1,,144209102,6758,Inconclusive,216409708.0,7421.0,7.0099,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1121,743222,3,1,,144211012,6758,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1122,743222,3,1,,170466816,6758,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1123,743223,3,1,,144209102,6758,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1124,743223,3,1,,144211012,6758,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1125,743223,3,1,,170466816,6758,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1126,743224,3,1,,144209102,6758,Inconclusive,,,0.0442,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1127,743224,3,1,,144211012,6758,Inconclusive,,,0.0871,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1128,743224,3,1,,170466816,6758,Inconclusive,,,1.6784,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1129,743225,3,1,,144209102,6758,Inconclusive,,,0.099,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1130,743225,3,1,,144211012,6758,Inconclusive,,,0.0616,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1131,743225,3,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1132,743226,2,1,,144209102,6758,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1133,743226,2,1,,144211012,6758,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1134,743226,2,1,,170466816,6758,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1135,743227,2,1,,144209102,6758,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1136,743227,2,1,,144211012,6758,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1137,743227,2,1,,170466816,6758,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1138,743228,3,1,,144209102,6758,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1139,743228,3,1,,144211012,6758,Inconclusive,4504517.0,3315.0,54.941,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1140,743228,3,1,,170466816,6758,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1141,743239,2,1,,144209102,6758,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1142,743239,2,1,,144211012,6758,Inconclusive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1143,743239,2,1,,170466816,6758,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1144,743240,2,1,,144209102,6758,Active,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1145,743240,2,1,,144211012,6758,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1146,743240,2,1,,170466816,6758,Active,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1147,743241,2,1,,144209102,6758,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1148,743241,2,1,,144211012,6758,Inconclusive,216409708.0,7421.0,8.220469999999999,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1149,743241,2,1,,170466816,6758,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1150,743242,2,1,,144209102,6758,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1151,743242,2,1,,144211012,6758,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1152,743242,2,1,,170466816,6758,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1153,743244,1,1,,90340839,6758,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1154,743244,1,1,,144204370,6758,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1155,743288,1,1,,26753652,6758,Inconclusive,,,1.122,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1156,743292,1,1,,26753652,6758,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1157,743322,2,1,,174007489,6758,Inactive,,,0.0038,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
1158,743323,2,1,,174007489,6758,Inactive,,,,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
1159,743324,2,1,,174007489,6758,Inactive,,,16.7744,Potency,qHTS profiling for inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
1160,743344,1,1,,174007489,6758,Inactive,,,18.8212,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
1161,743345,1,1,,174007489,6758,Inactive,,,0.003,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
1162,743346,1,1,,174007489,6758,Inactive,,,0.0053,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
1163,743347,1,1,,174007489,6758,Inactive,,,7.4929,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
1164,762959,1,2,,103166269,6758,Unspecified,,,,,"Chemopreventive index, ratio of CD for quinone reductase in mouse Hepa1c1c7 cells to IC50 for mouse Hepa1c1c7 cells",Other,23895019.0,
1165,762960,1,3,,103166269,6758,Active,,,0.7,IC50,Cytotoxicity against mouse Hepa-1c1c7 cells,Confirmatory,23895019.0,
1166,762961,1,2,,103166269,6758,Active,,,,,Induction of quinone reductase in mouse Hepa1c1c7 cells,Other,23895019.0,
1167,762964,1,2,,103166269,6758,Unspecified,,,,,Selectivity ratio of IC50 for human CCD-112CoN cells to IC50 for human HT29 cells,Other,23895019.0,
1168,762965,1,3,,103166269,6758,Unspecified,,,127.0,IC50,Cytotoxicity against human CCD-112CoN cells by SRB assay,Confirmatory,23895019.0,
1169,762966,1,2,,103166269,6758,Active,,,1.1,IC50,Cytotoxicity against human Raji cells after 72 hrs by MTS assay,Confirmatory,23895019.0,
1170,762967,1,2,,103166269,6758,Active,,,0.3,IC50,Cytotoxicity against human 697 cells after 72 hrs by MTS assay,Confirmatory,23895019.0,
1171,762968,1,2,,103166269,6758,Active,,,4.2,IC50,Cytotoxicity against human Raji cells after 48 hrs by MTS assay,Confirmatory,23895019.0,
1172,762969,1,2,,103166269,6758,Active,,,0.3,IC50,Cytotoxicity against human 697 cells after 48 hrs by MTS assay,Confirmatory,23895019.0,
1173,762970,1,2,,103166269,6758,Active,,,0.3,IC50,Cytotoxicity against human HT-29 cells after 72 hrs by SRB assay,Confirmatory,23895019.0,
1174,774892,3,1,,103166269,6758,Active,,,0.0051,IC50,Inhibition of NADH oxidase in beef heart sub-mitochondrial particles by UV-spectrophotometric analysis,Confirmatory,24012711.0,
1175,827093,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/12,Other,,
1176,827094,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/12,Other,,
1177,827095,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/12,Other,,
1178,827096,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/12,Other,,
1179,827097,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/12,Other,,
1180,827098,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/12,Other,,
1181,827099,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/12,Other,,
1182,827100,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/12,Other,,
1183,827101,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/12,Other,,
1184,827102,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/12,Other,,
1185,827103,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/12,Other,,
1186,827104,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/13,Other,,
1187,827105,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/13,Other,,
1188,827106,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/13,Other,,
1189,827107,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/13,Other,,
1190,827108,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/13,Other,,
1191,827109,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/13,Other,,
1192,827110,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/13,Other,,
1193,827111,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/13,Other,,
1194,827112,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/13,Other,,
1195,827113,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/13,Other,,
1196,827114,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/13,Other,,
1197,827115,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/13,Other,,
1198,827116,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/13,Other,,
1199,827117,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/13,Other,,
1200,827118,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/13,Other,,
1201,827119,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/13,Other,,
1202,827120,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/13,Other,,
1203,827121,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/14,Other,,
1204,827122,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/14,Other,,
1205,827123,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/14,Other,,
1206,827124,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/14,Other,,
1207,827125,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/14,Other,,
1208,827126,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/14,Other,,
1209,827127,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/14,Other,,
1210,827128,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/14,Other,,
1211,827129,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/14,Other,,
1212,827130,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/14,Other,,
1213,827131,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/14,Other,,
1214,827132,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/14,Other,,
1215,827133,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/14,Other,,
1216,827134,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/14,Other,,
1217,827135,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/14,Other,,
1218,827663,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/14,Other,,
1219,827664,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/14,Other,,
1220,827665,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/15,Other,,
1221,827666,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/15,Other,,
1222,827818,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/13,Other,,
1223,827819,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/13,Other,,
1224,827820,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/13,Other,,
1225,827821,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/13,Other,,
1226,827822,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/13,Other,,
1227,827823,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/13,Other,,
1228,827824,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/13,Other,,
1229,827825,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/13,Other,,
1230,827826,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/13,Other,,
1231,827827,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/13,Other,,
1232,827828,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/13,Other,,
1233,827829,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/13,Other,,
1234,827830,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/14,Other,,
1235,827831,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/14,Other,,
1236,827832,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/14,Other,,
1237,827833,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/14,Other,,
1238,827834,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/14,Other,,
1239,827835,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/14,Other,,
1240,827836,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/14,Other,,
1241,827837,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/14,Other,,
1242,827838,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/14,Other,,
1243,827839,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/14,Other,,
1244,828389,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/14,Other,,
1245,828390,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/14,Other,,
1246,828391,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/14,Other,,
1247,828392,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/14,Other,,
1248,828393,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/14,Other,,
1249,828394,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/14,Other,,
1250,828395,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/14,Other,,
1251,828396,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/15,Other,,
1252,828397,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/15,Other,,
1253,828398,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/15,Other,,
1254,828399,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/15,Other,,
1255,828400,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/15,Other,,
1256,828401,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/15,Other,,
1257,828402,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/15,Other,,
1258,828403,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/15,Other,,
1259,828404,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/15,Other,,
1260,828405,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/15,Other,,
1261,828406,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/15,Other,,
1262,828407,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/15,Other,,
1263,828408,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/15,Other,,
1264,828409,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/15,Other,,
1265,828410,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/15,Other,,
1266,828411,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/15,Other,,
1267,828412,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/15,Other,,
1268,828413,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/16,Other,,
1269,828414,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/16,Other,,
1270,828735,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/5,Other,,
1271,828736,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/5,Other,,
1272,828737,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/5,Other,,
1273,829228,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/5,Other,,
1274,829229,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/5,Other,,
1275,829230,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/5,Other,,
1276,829231,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/5,Other,,
1277,829232,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/5,Other,,
1278,829233,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/5,Other,,
1279,829234,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/5,Other,,
1280,829235,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/5,Other,,
1281,829236,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/5,Other,,
1282,829237,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/5,Other,,
1283,829238,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/5,Other,,
1284,829239,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/5,Other,,
1285,829240,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/5,Other,,
1286,829241,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/5,Other,,
1287,829242,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/6,Other,,
1288,829243,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/6,Other,,
1289,829244,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/6,Other,,
1290,829245,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/6,Other,,
1291,829246,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/6,Other,,
1292,829247,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/6,Other,,
1293,829248,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/6,Other,,
1294,829249,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/6,Other,,
1295,829250,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/6,Other,,
1296,829251,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/6,Other,,
1297,829252,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/6,Other,,
1298,829253,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/6,Other,,
1299,829254,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/6,Other,,
1300,829255,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/6,Other,,
1301,829256,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/6,Other,,
1302,829257,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/6,Other,,
1303,829258,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/6,Other,,
1304,829259,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/7,Other,,
1305,829260,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/7,Other,,
1306,829261,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/7,Other,,
1307,829262,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/7,Other,,
1308,829263,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/7,Other,,
1309,829264,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/7,Other,,
1310,829265,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/7,Other,,
1311,829266,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/7,Other,,
1312,829267,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/7,Other,,
1313,829268,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/7,Other,,
1314,829269,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/7,Other,,
1315,829270,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/7,Other,,
1316,829372,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/15,Other,,
1317,829373,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/15,Other,,
1318,829374,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/15,Other,,
1319,829375,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/15,Other,,
1320,829376,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/15,Other,,
1321,829377,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/15,Other,,
1322,829378,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/15,Other,,
1323,829379,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/15,Other,,
1324,829380,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/15,Other,,
1325,829381,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/15,Other,,
1326,829382,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/15,Other,,
1327,829383,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/15,Other,,
1328,829384,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/15,Other,,
1329,829385,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/15,Other,,
1330,829386,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/15,Other,,
1331,829387,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/16,Other,,
1332,829388,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/16,Other,,
1333,829389,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/16,Other,,
1334,829390,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/16,Other,,
1335,829391,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/16,Other,,
1336,829392,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/16,Other,,
1337,829393,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/16,Other,,
1338,829394,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/16,Other,,
1339,829395,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/16,Other,,
1340,829396,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/16,Other,,
1341,829397,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/16,Other,,
1342,829398,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/16,Other,,
1343,829399,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/16,Other,,
1344,829400,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/16,Other,,
1345,829401,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/16,Other,,
1346,829402,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/16,Other,,
1347,829403,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/16,Other,,
1348,830083,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/16,Other,,
1349,830084,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/16,Other,,
1350,830085,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/16,Other,,
1351,830086,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/16,Other,,
1352,830087,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/16,Other,,
1353,830088,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/16,Other,,
1354,830089,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/16,Other,,
1355,830090,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/16,Other,,
1356,830091,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/16,Other,,
1357,830092,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/16,Other,,
1358,830093,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/16,Other,,
1359,830094,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/16,Other,,
1360,830661,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/16,Other,,
1361,830662,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/16,Other,,
1362,830663,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/16,Other,,
1363,830664,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/5,Other,,
1364,830665,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/5,Other,,
1365,830666,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/5,Other,,
1366,830667,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/5,Other,,
1367,830668,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/5,Other,,
1368,830669,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/5,Other,,
1369,830670,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/5,Other,,
1370,830671,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/5,Other,,
1371,830672,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/5,Other,,
1372,830673,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/5,Other,,
1373,830674,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/5,Other,,
1374,830675,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/5,Other,,
1375,830676,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/5,Other,,
1376,830677,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/5,Other,,
1377,830678,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/5,Other,,
1378,830679,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/5,Other,,
1379,830680,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/5,Other,,
1380,830681,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/6,Other,,
1381,830682,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/6,Other,,
1382,830683,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/6,Other,,
1383,830684,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/6,Other,,
1384,830685,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/6,Other,,
1385,830686,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/6,Other,,
1386,830687,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/6,Other,,
1387,830688,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/6,Other,,
1388,830689,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/6,Other,,
1389,830690,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/6,Other,,
1390,830691,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/6,Other,,
1391,830692,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/6,Other,,
1392,830693,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/6,Other,,
1393,830694,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/6,Other,,
1394,830695,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/6,Other,,
1395,832247,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/7,Other,,
1396,832248,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/7,Other,,
1397,832249,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/7,Other,,
1398,832250,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/7,Other,,
1399,832251,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/7,Other,,
1400,832252,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/8,Other,,
1401,832253,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/8,Other,,
1402,832254,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/8,Other,,
1403,832255,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/8,Other,,
1404,832256,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/8,Other,,
1405,832257,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/8,Other,,
1406,832258,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/8,Other,,
1407,832259,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/8,Other,,
1408,832260,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/8,Other,,
1409,832261,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/8,Other,,
1410,832262,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/8,Other,,
1411,832263,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/8,Other,,
1412,832264,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/8,Other,,
1413,832265,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/8,Other,,
1414,832266,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/8,Other,,
1415,832267,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/8,Other,,
1416,832268,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/8,Other,,
1417,832269,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/9,Other,,
1418,832270,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/9,Other,,
1419,832271,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/9,Other,,
1420,832272,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/9,Other,,
1421,832273,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/9,Other,,
1422,832274,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/9,Other,,
1423,832275,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/9,Other,,
1424,832276,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/9,Other,,
1425,832277,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/9,Other,,
1426,832278,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/9,Other,,
1427,832279,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/9,Other,,
1428,832280,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/9,Other,,
1429,832281,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/9,Other,,
1430,832282,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/9,Other,,
1431,832283,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/9,Other,,
1432,832284,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/9,Other,,
1433,832285,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/9,Other,,
1434,832286,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/10,Other,,
1435,832329,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/6,Other,,
1436,832330,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/6,Other,,
1437,832331,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/7,Other,,
1438,832857,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/10,Other,,
1439,832858,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/10,Other,,
1440,832859,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/10,Other,,
1441,832860,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/10,Other,,
1442,832861,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/10,Other,,
1443,832862,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/10,Other,,
1444,832863,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/10,Other,,
1445,832864,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/10,Other,,
1446,832900,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/7,Other,,
1447,832901,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/7,Other,,
1448,832902,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/7,Other,,
1449,832903,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/7,Other,,
1450,832904,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/7,Other,,
1451,832905,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/7,Other,,
1452,832906,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/7,Other,,
1453,832907,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/7,Other,,
1454,832908,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/7,Other,,
1455,832909,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/7,Other,,
1456,832910,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/7,Other,,
1457,832911,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/7,Other,,
1458,832912,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/7,Other,,
1459,832913,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/7,Other,,
1460,832914,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/7,Other,,
1461,832915,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/7,Other,,
1462,832916,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/8,Other,,
1463,832917,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/8,Other,,
1464,832918,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/8,Other,,
1465,832919,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/8,Other,,
1466,832920,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/8,Other,,
1467,832921,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/8,Other,,
1468,832922,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/8,Other,,
1469,832923,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/8,Other,,
1470,832924,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/8,Other,,
1471,832925,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/8,Other,,
1472,832926,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/8,Other,,
1473,832927,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/8,Other,,
1474,832928,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/8,Other,,
1475,832929,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/8,Other,,
1476,832930,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/8,Other,,
1477,832931,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/8,Other,,
1478,832932,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/8,Other,,
1479,832933,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/9,Other,,
1480,832934,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/9,Other,,
1481,832935,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/9,Other,,
1482,832936,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/9,Other,,
1483,832937,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/9,Other,,
1484,832938,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/9,Other,,
1485,832939,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/9,Other,,
1486,832940,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/9,Other,,
1487,832941,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/9,Other,,
1488,832942,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/9,Other,,
1489,832943,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/9,Other,,
1490,834524,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/10,Other,,
1491,834525,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/10,Other,,
1492,834526,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/10,Other,,
1493,834527,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/10,Other,,
1494,834528,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/10,Other,,
1495,834529,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/10,Other,,
1496,834530,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/10,Other,,
1497,834531,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/10,Other,,
1498,834532,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/11,Other,,
1499,834533,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/11,Other,,
1500,834534,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/11,Other,,
1501,834535,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/11,Other,,
1502,834536,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/11,Other,,
1503,834537,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/11,Other,,
1504,834538,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/11,Other,,
1505,834539,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/11,Other,,
1506,834540,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/11,Other,,
1507,834541,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/11,Other,,
1508,834542,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/11,Other,,
1509,834543,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/11,Other,,
1510,834544,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/11,Other,,
1511,834545,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/11,Other,,
1512,834546,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/11,Other,,
1513,834547,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/11,Other,,
1514,834548,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/11,Other,,
1515,834549,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/12,Other,,
1516,834550,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/12,Other,,
1517,834551,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/12,Other,,
1518,834552,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/12,Other,,
1519,834553,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/12,Other,,
1520,834554,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 669/12,Other,,
1521,834555,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 669/12,Other,,
1522,835144,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 669/12,Other,,
1523,835145,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 669/12,Other,,
1524,835146,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 669/12,Other,,
1525,835147,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 669/12,Other,,
1526,835148,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 669/12,Other,,
1527,835149,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 669/12,Other,,
1528,835150,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 669/12,Other,,
1529,835151,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 669/12,Other,,
1530,835152,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 669/12,Other,,
1531,835153,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 669/12,Other,,
1532,835154,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 669/13,Other,,
1533,835155,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 669/13,Other,,
1534,835156,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 669/13,Other,,
1535,835157,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 669/13,Other,,
1536,835158,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 669/13,Other,,
1537,835195,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/9,Other,,
1538,835196,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/9,Other,,
1539,835197,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/9,Other,,
1540,835198,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/9,Other,,
1541,835199,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/9,Other,,
1542,835200,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/9,Other,,
1543,835201,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/10,Other,,
1544,835202,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/10,Other,,
1545,835203,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/10,Other,,
1546,835204,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/10,Other,,
1547,835205,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/10,Other,,
1548,835206,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/10,Other,,
1549,835207,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/10,Other,,
1550,835208,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/10,Other,,
1551,835209,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/10,Other,,
1552,835210,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/10,Other,,
1553,835211,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/10,Other,,
1554,835212,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/10,Other,,
1555,835213,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/10,Other,,
1556,835214,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/10,Other,,
1557,835215,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/10,Other,,
1558,835216,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/10,Other,,
1559,835217,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/10,Other,,
1560,835218,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/11,Other,,
1561,835219,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/11,Other,,
1562,835220,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/11,Other,,
1563,835221,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/11,Other,,
1564,835222,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/11,Other,,
1565,835223,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/11,Other,,
1566,835224,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 670/11,Other,,
1567,835225,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 670/11,Other,,
1568,835226,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 670/11,Other,,
1569,835227,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 670/11,Other,,
1570,835228,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 670/11,Other,,
1571,835229,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 670/11,Other,,
1572,835230,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 670/11,Other,,
1573,835760,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 670/11,Other,,
1574,835761,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 670/11,Other,,
1575,835762,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 670/11,Other,,
1576,835763,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 670/11,Other,,
1577,835764,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 670/12,Other,,
1578,835765,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 670/12,Other,,
1579,835766,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 670/12,Other,,
1580,835767,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 670/12,Other,,
1581,835768,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 670/12,Other,,
1582,835769,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 670/12,Other,,
1583,908887,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/15,Other,,
1584,908888,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/15,Other,,
1585,908889,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/15,Other,,
1586,908890,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/15,Other,,
1587,908891,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/15,Other,,
1588,908892,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/15,Other,,
1589,908893,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/15,Other,,
1590,908894,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/15,Other,,
1591,908895,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/15,Other,,
1592,908896,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/15,Other,,
1593,908897,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/15,Other,,
1594,908898,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/15,Other,,
1595,908899,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/15,Other,,
1596,908900,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/15,Other,,
1597,908901,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/15,Other,,
1598,908902,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/15,Other,,
1599,908903,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/15,Other,,
1600,908904,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/15,Other,,
1601,908905,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/16,Other,,
1602,908906,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/16,Other,,
1603,908907,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/16,Other,,
1604,908908,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/16,Other,,
1605,908909,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/16,Other,,
1606,908910,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/16,Other,,
1607,908911,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/16,Other,,
1608,909754,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/13,Other,,
1609,909755,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/13,Other,,
1610,909756,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/13,Other,,
1611,909757,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/13,Other,,
1612,909758,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/13,Other,,
1613,909759,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/13,Other,,
1614,909760,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/13,Other,,
1615,909761,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/13,Other,,
1616,909762,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/13,Other,,
1617,909763,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/13,Other,,
1618,909764,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/13,Other,,
1619,909765,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/13,Other,,
1620,909766,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/13,Other,,
1621,909767,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/13,Other,,
1622,909768,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/14,Other,,
1623,909769,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/14,Other,,
1624,909770,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/14,Other,,
1625,909771,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/14,Other,,
1626,909772,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/14,Other,,
1627,909773,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/14,Other,,
1628,909774,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/14,Other,,
1629,909775,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/14,Other,,
1630,909776,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/14,Other,,
1631,909777,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/14,Other,,
1632,909778,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/14,Other,,
1633,909779,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/14,Other,,
1634,909780,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/14,Other,,
1635,909781,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/14,Other,,
1636,909867,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/7,Other,,
1637,909868,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/7,Other,,
1638,909869,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/7,Other,,
1639,909870,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/7,Other,,
1640,909871,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/7,Other,,
1641,910133,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/14,Other,,
1642,910134,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/14,Other,,
1643,910135,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/14,Other,,
1644,910136,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/14,Other,,
1645,910137,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/14,Other,,
1646,910138,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/14,Other,,
1647,910139,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/14,Other,,
1648,910140,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/15,Other,,
1649,910141,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/15,Other,,
1650,910142,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/15,Other,,
1651,910143,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/15,Other,,
1652,910144,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/15,Other,,
1653,910145,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/15,Other,,
1654,910146,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/15,Other,,
1655,910147,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/15,Other,,
1656,910148,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/15,Other,,
1657,910149,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/15,Other,,
1658,910150,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/15,Other,,
1659,910151,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/15,Other,,
1660,910222,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/7,Other,,
1661,910223,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/7,Other,,
1662,910224,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/7,Other,,
1663,910225,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/7,Other,,
1664,910226,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/7,Other,,
1665,910227,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/7,Other,,
1666,910228,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/7,Other,,
1667,910229,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/7,Other,,
1668,910230,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/7,Other,,
1669,910231,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/7,Other,,
1670,910232,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/7,Other,,
1671,910233,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/7,Other,,
1672,910234,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/8,Other,,
1673,910235,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/8,Other,,
1674,910236,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/8,Other,,
1675,910237,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/8,Other,,
1676,910238,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/8,Other,,
1677,910239,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/8,Other,,
1678,910240,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/8,Other,,
1679,910241,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/8,Other,,
1680,910242,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/8,Other,,
1681,910243,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/8,Other,,
1682,910244,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/8,Other,,
1683,910245,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/8,Other,,
1684,910246,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/8,Other,,
1685,910247,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/8,Other,,
1686,910248,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/8,Other,,
1687,910249,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/8,Other,,
1688,910250,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/8,Other,,
1689,910251,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/8,Other,,
1690,910252,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/8,Other,,
1691,910253,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/8,Other,,
1692,910254,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/8,Other,,
1693,910255,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/9,Other,,
1694,910256,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/9,Other,,
1695,910257,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/9,Other,,
1696,910258,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/9,Other,,
1697,910259,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/9,Other,,
1698,910260,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/9,Other,,
1699,910261,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/9,Other,,
1700,910262,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/9,Other,,
1701,910263,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/9,Other,,
1702,910264,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/9,Other,,
1703,911096,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/6,Other,,
1704,911097,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/6,Other,,
1705,911098,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/6,Other,,
1706,911099,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/6,Other,,
1707,911100,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/6,Other,,
1708,911101,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/6,Other,,
1709,911102,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/6,Other,,
1710,911103,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/6,Other,,
1711,911104,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/7,Other,,
1712,911105,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/7,Other,,
1713,911106,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/7,Other,,
1714,911107,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/7,Other,,
1715,911108,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/7,Other,,
1716,911109,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/7,Other,,
1717,911110,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/7,Other,,
1718,911559,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/7,Other,,
1719,911560,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/7,Other,,
1720,911561,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/7,Other,,
1721,911562,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/7,Other,,
1722,911563,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/7,Other,,
1723,911564,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/7,Other,,
1724,911565,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/7,Other,,
1725,911566,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/7,Other,,
1726,911567,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/7,Other,,
1727,911568,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/7,Other,,
1728,911569,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/7,Other,,
1729,911570,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/7,Other,,
1730,911571,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/7,Other,,
1731,911572,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/7,Other,,
1732,911573,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/8,Other,,
1733,911574,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/8,Other,,
1734,911575,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/8,Other,,
1735,911576,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/8,Other,,
1736,911577,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/8,Other,,
1737,911578,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/8,Other,,
1738,911579,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/8,Other,,
1739,911580,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/8,Other,,
1740,911581,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/8,Other,,
1741,911582,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/8,Other,,
1742,911583,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/8,Other,,
1743,911584,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/8,Other,,
1744,911585,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/8,Other,,
1745,911586,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/8,Other,,
1746,911587,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/8,Other,,
1747,911588,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/8,Other,,
1748,911589,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/8,Other,,
1749,911590,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/8,Other,,
1750,911629,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/15,Other,,
1751,911630,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/15,Other,,
1752,911631,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/15,Other,,
1753,911632,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/15,Other,,
1754,911633,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/15,Other,,
1755,911634,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/15,Other,,
1756,911635,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/15,Other,,
1757,911636,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/15,Other,,
1758,911637,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/15,Other,,
1759,911638,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/16,Other,,
1760,911639,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/16,Other,,
1761,911640,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/16,Other,,
1762,911641,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/16,Other,,
1763,911642,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/16,Other,,
1764,911643,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/16,Other,,
1765,911644,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/16,Other,,
1766,911645,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/16,Other,,
1767,911646,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/16,Other,,
1768,911647,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/16,Other,,
1769,912019,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/16,Other,,
1770,912020,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/16,Other,,
1771,912021,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/16,Other,,
1772,912022,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/16,Other,,
1773,912023,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/16,Other,,
1774,912024,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/16,Other,,
1775,912025,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/16,Other,,
1776,912026,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/16,Other,,
1777,912027,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/16,Other,,
1778,912028,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/16,Other,,
1779,912029,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/16,Other,,
1780,912113,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/9,Other,,
1781,912114,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/9,Other,,
1782,912115,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/9,Other,,
1783,912116,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/9,Other,,
1784,912117,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/9,Other,,
1785,912118,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/9,Other,,
1786,912119,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/9,Other,,
1787,912120,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/9,Other,,
1788,912121,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/9,Other,,
1789,912122,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/9,Other,,
1790,912123,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/9,Other,,
1791,912124,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/10,Other,,
1792,912125,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/10,Other,,
1793,912126,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/10,Other,,
1794,912127,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/10,Other,,
1795,912128,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/10,Other,,
1796,912129,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/10,Other,,
1797,912130,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/10,Other,,
1798,912131,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/10,Other,,
1799,912132,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/10,Other,,
1800,912133,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/10,Other,,
1801,912134,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/10,Other,,
1802,912135,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/10,Other,,
1803,912136,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/10,Other,,
1804,912137,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/10,Other,,
1805,912138,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/10,Other,,
1806,912139,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/10,Other,,
1807,912140,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/10,Other,,
1808,912141,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/10,Other,,
1809,912142,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/10,Other,,
1810,912143,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/10,Other,,
1811,912144,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/10,Other,,
1812,912145,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/11,Other,,
1813,912146,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/11,Other,,
1814,912147,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/11,Other,,
1815,912148,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/11,Other,,
1816,912149,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/11,Other,,
1817,912150,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/11,Other,,
1818,912151,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/11,Other,,
1819,912152,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/11,Other,,
1820,912153,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/11,Other,,
1821,912154,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/11,Other,,
1822,912531,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/11,Other,,
1823,912532,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/11,Other,,
1824,912533,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/11,Other,,
1825,912534,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/11,Other,,
1826,912535,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/11,Other,,
1827,912536,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/11,Other,,
1828,912952,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/8,Other,,
1829,912953,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/8,Other,,
1830,912954,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/8,Other,,
1831,912955,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/9,Other,,
1832,912956,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/9,Other,,
1833,913387,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/9,Other,,
1834,913388,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/9,Other,,
1835,913389,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/9,Other,,
1836,913390,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/9,Other,,
1837,913391,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/9,Other,,
1838,913392,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/9,Other,,
1839,913393,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/9,Other,,
1840,913394,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/9,Other,,
1841,913395,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/9,Other,,
1842,913396,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/9,Other,,
1843,913397,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/9,Other,,
1844,913398,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/9,Other,,
1845,913399,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/9,Other,,
1846,913400,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/9,Other,,
1847,913401,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/9,Other,,
1848,913402,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/9,Other,,
1849,913403,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/9,Other,,
1850,913404,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/9,Other,,
1851,913405,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/9,Other,,
1852,913406,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/10,Other,,
1853,913407,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/10,Other,,
1854,913408,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/10,Other,,
1855,913409,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/10,Other,,
1856,913410,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/10,Other,,
1857,913411,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/10,Other,,
1858,913412,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/10,Other,,
1859,913413,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/10,Other,,
1860,913414,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/10,Other,,
1861,913415,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/10,Other,,
1862,913416,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/10,Other,,
1863,913417,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/10,Other,,
1864,913418,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/10,Other,,
1865,913419,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/10,Other,,
1866,913420,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/10,Other,,
1867,913421,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/10,Other,,
1868,913422,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/10,Other,,
1869,913423,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/10,Other,,
1870,913424,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/10,Other,,
1871,913425,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/10,Other,,
1872,913426,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/10,Other,,
1873,913427,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/11,Other,,
1874,913428,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/11,Other,,
1875,913955,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/11,Other,,
1876,913956,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/11,Other,,
1877,913957,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/11,Other,,
1878,913958,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/11,Other,,
1879,913959,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/11,Other,,
1880,913960,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/12,Other,,
1881,913961,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/12,Other,,
1882,913962,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/12,Other,,
1883,913963,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/12,Other,,
1884,913964,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/12,Other,,
1885,913965,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/12,Other,,
1886,913966,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/12,Other,,
1887,913967,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/12,Other,,
1888,913968,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/12,Other,,
1889,913969,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/12,Other,,
1890,913970,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/12,Other,,
1891,913971,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/12,Other,,
1892,913972,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/12,Other,,
1893,913973,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/12,Other,,
1894,913974,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/12,Other,,
1895,913975,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/12,Other,,
1896,913976,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/12,Other,,
1897,913977,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/12,Other,,
1898,913978,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/12,Other,,
1899,913979,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/12,Other,,
1900,913980,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/12,Other,,
1901,913981,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/13,Other,,
1902,913982,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/13,Other,,
1903,913983,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/13,Other,,
1904,913984,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/13,Other,,
1905,913985,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/13,Other,,
1906,913986,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/13,Other,,
1907,913987,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/13,Other,,
1908,914350,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/13,Other,,
1909,914351,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/13,Other,,
1910,914352,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/13,Other,,
1911,914353,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/13,Other,,
1912,914354,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/13,Other,,
1913,914355,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/13,Other,,
1914,914356,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/13,Other,,
1915,914357,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/13,Other,,
1916,914358,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/13,Other,,
1917,914359,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/13,Other,,
1918,914360,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/13,Other,,
1919,914361,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/13,Other,,
1920,914362,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/13,Other,,
1921,914363,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/13,Other,,
1922,914364,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/14,Other,,
1923,915220,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/11,Other,,
1924,915221,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/11,Other,,
1925,915222,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/11,Other,,
1926,915223,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/11,Other,,
1927,915224,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/11,Other,,
1928,915225,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/11,Other,,
1929,915226,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/11,Other,,
1930,915227,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/11,Other,,
1931,915228,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/11,Other,,
1932,915229,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/11,Other,,
1933,915230,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/11,Other,,
1934,915231,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/11,Other,,
1935,915232,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/11,Other,,
1936,915233,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/11,Other,,
1937,915234,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/11,Other,,
1938,915235,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/11,Other,,
1939,915236,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/11,Other,,
1940,915237,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/11,Other,,
1941,915238,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/11,Other,,
1942,915239,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/12,Other,,
1943,915240,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/12,Other,,
1944,915241,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/12,Other,,
1945,915242,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/12,Other,,
1946,915243,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/12,Other,,
1947,915244,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/12,Other,,
1948,915245,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/12,Other,,
1949,915246,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/12,Other,,
1950,915247,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/12,Other,,
1951,915248,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/12,Other,,
1952,915249,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/12,Other,,
1953,915250,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/12,Other,,
1954,915251,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/12,Other,,
1955,915252,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/12,Other,,
1956,915253,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/12,Other,,
1957,915254,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/12,Other,,
1958,915255,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/12,Other,,
1959,915256,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/12,Other,,
1960,915257,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/12,Other,,
1961,915337,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/5,Other,,
1962,915338,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/5,Other,,
1963,915339,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/5,Other,,
1964,915340,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/5,Other,,
1965,915341,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/5,Other,,
1966,915342,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/5,Other,,
1967,915343,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/5,Other,,
1968,915344,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/5,Other,,
1969,915345,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/5,Other,,
1970,915346,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/5,Other,,
1971,915348,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/5,Other,,
1972,915610,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/12,Other,,
1973,915611,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/12,Other,,
1974,915612,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/13,Other,,
1975,915613,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/13,Other,,
1976,915614,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/13,Other,,
1977,915615,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/13,Other,,
1978,915616,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/13,Other,,
1979,915617,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/13,Other,,
1980,915618,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/13,Other,,
1981,915699,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/5,Other,,
1982,915700,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/5,Other,,
1983,915701,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/5,Other,,
1984,915702,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/5,Other,,
1985,915703,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/5,Other,,
1986,915704,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/5,Other,,
1987,915705,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/5,Other,,
1988,915706,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/5,Other,,
1989,915707,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/5,Other,,
1990,915708,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/5,Other,,
1991,915709,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/6,Other,,
1992,915710,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/6,Other,,
1993,915711,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/6,Other,,
1994,915712,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/6,Other,,
1995,915713,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/6,Other,,
1996,915714,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/6,Other,,
1997,915715,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/6,Other,,
1998,915716,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/6,Other,,
1999,915717,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/6,Other,,
2000,915718,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/6,Other,,
2001,915719,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/6,Other,,
2002,915720,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/6,Other,,
2003,915721,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/6,Other,,
2004,915722,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/6,Other,,
2005,915723,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/6,Other,,
2006,915724,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/6,Other,,
2007,915725,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/6,Other,,
2008,915726,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/6,Other,,
2009,915727,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/6,Other,,
2010,915728,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/6,Other,,
2011,915729,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/6,Other,,
2012,915730,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/7,Other,,
2013,915731,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/7,Other,,
2014,915732,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/7,Other,,
2015,915733,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/7,Other,,
2016,915768,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/14,Other,,
2017,915769,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/14,Other,,
2018,915770,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 669/14,Other,,
2019,915771,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 669/14,Other,,
2020,915772,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 669/14,Other,,
2021,915773,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 669/14,Other,,
2022,915774,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/14,Other,,
2023,915775,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/14,Other,,
2024,915776,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/14,Other,,
2025,915777,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/14,Other,,
2026,915778,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/14,Other,,
2027,915779,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/14,Other,,
2028,915780,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/14,Other,,
2029,915781,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/14,Other,,
2030,915782,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/14,Other,,
2031,915783,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/14,Other,,
2032,915784,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/14,Other,,
2033,915785,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/14,Other,,
2034,915786,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/14,Other,,
2035,915787,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/14,Other,,
2036,915788,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 669/15,Other,,
2037,915789,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 669/15,Other,,
2038,915790,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 669/15,Other,,
2039,916701,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 669/16,Other,,
2040,916702,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 669/16,Other,,
2041,916703,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 669/16,Other,,
2042,916704,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 669/16,Other,,
2043,916705,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 669/16,Other,,
2044,916706,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 669/16,Other,,
2045,916707,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 669/16,Other,,
2046,916708,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 669/16,Other,,
2047,916709,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 669/16,Other,,
2048,916710,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 669/16,Other,,
2049,916711,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 669/16,Other,,
2050,916712,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 669/16,Other,,
2051,916713,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 669/16,Other,,
2052,916714,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 669/16,Other,,
2053,916715,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/5,Other,,
2054,916716,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/5,Other,,
2055,916717,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/5,Other,,
2056,916718,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/5,Other,,
2057,916719,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/5,Other,,
2058,916720,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/5,Other,,
2059,916721,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/5,Other,,
2060,916722,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/5,Other,,
2061,916723,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/5,Other,,
2062,916724,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/5,Other,,
2063,917175,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/5,Other,,
2064,917176,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/5,Other,,
2065,917177,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/5,Other,,
2066,917178,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 670/5,Other,,
2067,917179,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 670/5,Other,,
2068,917180,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 670/5,Other,,
2069,917181,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 670/5,Other,,
2070,917182,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 670/5,Other,,
2071,917183,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 670/5,Other,,
2072,917184,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 670/5,Other,,
2073,917185,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 670/5,Other,,
2074,917186,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 670/6,Other,,
2075,917187,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 670/6,Other,,
2076,917188,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 670/6,Other,,
2077,917189,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 670/6,Other,,
2078,917190,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 670/6,Other,,
2079,917191,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 670/6,Other,,
2080,917192,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 670/6,Other,,
2081,917193,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 670/6,Other,,
2082,917194,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 670/6,Other,,
2083,917195,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 670/6,Other,,
2084,917196,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 670/6,Other,,
2085,917197,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 670/6,Other,,
2086,917198,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 670/6,Other,,
2087,977599,1,1,,103166269,6758,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
2088,977602,1,2,,103166269,6758,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
2089,1047757,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/5,Other,,
2090,1047758,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/5,Other,,
2091,1047759,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/6,Other,,
2092,1047760,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/6,Other,,
2093,1047761,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/7,Other,,
2094,1047762,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/7,Other,,
2095,1047763,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/8,Other,,
2096,1047852,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/8,Other,,
2097,1047853,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/9,Other,,
2098,1047854,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/9,Other,,
2099,1047855,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/10,Other,,
2100,1047856,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/10,Other,,
2101,1047857,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/11,Other,,
2102,1047858,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/11,Other,,
2103,1047859,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/12,Other,,
2104,1047860,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/12,Other,,
2105,1047861,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/13,Other,,
2106,1047862,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/13,Other,,
2107,1047863,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/14,Other,,
2108,1047864,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/14,Other,,
2109,1047865,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/15,Other,,
2110,1047866,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/15,Other,,
2111,1047867,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 669/16,Other,,
2112,1047868,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 669/16,Other,,
2113,1047869,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/5,Other,,
2114,1047870,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/5,Other,,
2115,1047871,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/6,Other,,
2116,1047872,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/6,Other,,
2117,1047873,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/7,Other,,
2118,1047874,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/7,Other,,
2119,1047875,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/8,Other,,
2120,1047876,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/8,Other,,
2121,1047877,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/9,Other,,
2122,1047878,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/9,Other,,
2123,1047879,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/10,Other,,
2124,1047880,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/10,Other,,
2125,1047881,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/11,Other,,
2126,1047882,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/11,Other,,
2127,1047883,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/12,Other,,
2128,1048154,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/12,Other,,
2129,1048155,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/13,Other,,
2130,1048156,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/13,Other,,
2131,1048157,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/14,Other,,
2132,1048158,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/14,Other,,
2133,1048159,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/15,Other,,
2134,1048160,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/15,Other,,
2135,1048161,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 670/16,Other,,
2136,1048162,1,2,,103166269,6758,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 670/16,Other,,
2137,1064563,1,1,,103166269,6758,Active,,,,,Induction of superoxide radical generation in bovine succinate-respiring submitochondrial particles assessed as oxidation of CPH at 50 uM after 2 mins by ESR spectroscopy,Other,24393721.0,
2138,1083028,1,1,,103166269,6758,Active,,,,,Inhibition of F1 generation emergence in adult Callosobruchus maculatus grown on compound pre-treated cowpea seeds assessed as reduction in adult emergence at 10 to 500 ppm measured over 2 weeks from start of F1 emergence,Other,22970736.0,
2139,1083029,1,1,,103166269,6758,Active,,,,,Inhibition of oviposition in adult Callosobruchus maculatus grown on compound pre-treated cowpea seeds assessed as reduction in number of eggs at 10 to 500 ppm measured after 72 hr,Other,22970736.0,
2140,1083030,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against adult Callosobruchus maculatus assessed reduction mean survival fraction measured 72 hr post dose (Rvb = 4.4 +/- 0.31 mean survival fraction),Other,22970736.0,
2141,1083031,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against adult Callosobruchus maculatus assessed mean survival fraction ratio at 10 ppm measured 72 hr post dose (Rvb = 4.4 +/- 0.31 mean survival fraction),Other,22970736.0,
2142,1083032,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against adult Callosobruchus maculatus assessed mean survival fraction ratio at 100 ppm measured 72 hr post dose (Rvb = 4.4 +/- 0.31 mean survival fraction),Other,22970736.0,
2143,1083033,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against adult Callosobruchus maculatus assessed mean survival fraction ratio at 500 ppm measured 72 hr post dose (Rvb = 4.4 +/- 0.31 mean survival fraction),Other,22970736.0,
2144,1090237,2,3,,103166269,6758,Inactive,14286096.0,42920.0,,IC50,Inhibition of adult Drosophila melanogaster AChE by colorimetric method,Confirmatory,15998112.0,
2145,1090238,1,1,,103166269,6758,Unspecified,,,,,"Relative toxicity, LD50 for rotenone Drosophila melanogaster adulticidal activity to LD50 for compound Drosophila melanogaster adulticidal activity",Other,15998112.0,
2146,1090239,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against 5 to 7 days old adult Drosophila melanogaster assessed as mortality measured as inability to move compound treated in diet at 25 degC and >90% RH treated for 8 days,Other,15998112.0,
2147,1090240,1,1,,103166269,6758,Unspecified,,,,,"Relative toxicity, LC50 for rotenone Drosophila melanogaster larvicidal activity to LC50 for compound Drosophila melanogaster larvicidal activity",Other,15998112.0,
2148,1090241,1,1,,103166269,6758,Active,,,20.0,LC50,Insecticidal activity against Drosophila melanogaster larvae assessed as mortality compound treated in diet at 25 degC and >90% RH treated for 8 days,Confirmatory,15998112.0,
2149,1092089,1,4,,103166269,6758,Inactive,14286096.0,42920.0,,,Inhibition of Drosophila melanogaster AChE by colorimetric method,Other,21639116.0,
2150,1092091,1,1,,103166269,6758,Unspecified,,,,,Adulticidal activity against adult Drosophila melanogaster (males/females 1:1 ratio) assessed as mortality measured after 3 hr,Other,21639116.0,
2151,1092159,1,1,,103166269,6758,Unspecified,,,,,Cytotoxicity against Spodoptera litura cells assessed as growth inhibition at 20 mg/L after 24 hr by MTT assay relative to control,Other,22901896.0,
2152,1100548,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality measured 48 hr after compound treatment,Other,52.0,
2153,1100549,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality measured 24 hr after compound treatment,Other,52.0,
2154,1100550,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 5 ug/ml measured 72 hr after compound treatment,Other,52.0,
2155,1100551,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 5 ug/ml measured 48 hr after compound treatment,Other,52.0,
2156,1100552,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 5 ug/ml measured 24 hr after compound treatment,Other,52.0,
2157,1100553,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 5 ug/ml measured 12 hr after compound treatment,Other,52.0,
2158,1100562,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 10 ug/ml measured 72 hr after compound treatment,Other,52.0,
2159,1100563,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 10 ug/ml measured 48 hr after compound treatment,Other,52.0,
2160,1100564,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 10 ug/ml measured 24 hr after compound treatment,Other,52.0,
2161,1100565,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 10 ug/ml measured 12 hr after compound treatment,Other,52.0,
2162,1100566,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 50 ug/ml measured 72 hr after compound treatment,Other,52.0,
2163,1100567,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 50 ug/ml measured 48 hr after compound treatment,Other,52.0,
2164,1100568,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 50 ug/ml measured 24 hr after compound treatment,Other,52.0,
2165,1100569,1,1,,103166269,6758,Unspecified,,,,,Insecticidal activity against Brontispa longissima fifth-instar larvae fed on compound pre-treated Cocos nucifera L. leaves assessed as insect mortality at 50 ug/ml measured 12 hr after compound treatment,Other,52.0,
2166,1100871,1,1,,103166269,6758,Unspecified,,,,,Antifeedant activity against Spodoptera litura in compound treated cork borer from fresh sweet potato leaves by Choice Leaf-Disk Bioassay,Other,10820110.0,
2167,1103506,2,3,,103166269,6758,Active,128632.0,,0.0044,IC50,Inhibition of Bos taurus (beef) heart NAD1,Confirmatory,16218678.0,
2168,1103608,1,1,,103166269,6758,Unspecified,,,,,Adulticidal activity against Drosophila melanogaster larvae assessed as mortality measured per adult,Other,16508176.0,
2169,1103610,1,1,,103166269,6758,Active,,,20.0,LC50,Larvicidal activity against Drosophila melanogaster larvae assessed as mortality administered through diet after 8 days,Confirmatory,16508176.0,
2170,1103916,1,1,,103166269,6758,Active,,,,,Disruption of mitochondria in insecticide-susceptible Drosophila melanogaster Hikone-R assessed as increase in cytochrome c release from mitochondria to cytosol at 1 mM by western blot analysis,Other,19278021.0,
2171,1103917,1,1,,103166269,6758,Active,,,,,Disruption of mitochondria in insecticide-susceptible Drosophila melanogaster Canton-S assessed as increase in cytochrome c release from mitochondria to cytosol at 1 mM by western blot analysis,Other,19278021.0,
2172,1103947,1,1,,103166269,6758,Unspecified,,,,,Antifeedant activity against third-instar Spodoptera litura assessed per cm2 leaf disk,Other,19342224.0,
2173,1105064,1,1,,103166269,6758,Inactive,,,,,Antifeedant activity against Diaprepes abbreviatus in compound treated Citrus paradisi MacFad (Rutaceae) potted plants assessed as reduction in leaf consumption measured under 12 hr sunlight exposure at 5.6 ml/l by No-choice tests,Other,21370392.0,
2174,1105065,1,1,,103166269,6758,Inactive,,,,,Antifeedant activity against Diaprepes abbreviatus in compound treated Citrus paradisi MacFad (Rutaceae) potted plants assessed as reduction in leaf consumption measured under 8 hr sunlight exposure at 5.6 ml/l by No-choice tests,Other,21370392.0,
2175,1105066,1,1,,103166269,6758,Inactive,,,,,Antifeedant activity against Diaprepes abbreviatus in compound treated Citrus paradisi MacFad (Rutaceae) potted plants assessed as reduction in leaf consumption measured under 4 hr sunlight exposure at 5.6 ml/l by No-choice tests,Other,21370392.0,
2176,1105080,1,1,,103166269,6758,Unspecified,,,,,Antifeedant activity against Diaprepes abbreviatus in compound treated healthy romaine lettuce plants assessed as area consumed from leaf disk at 48 g/l by No-choice tests (2.51 +/- 0.2 cm'2),Other,21370392.0,
2177,1105081,1,1,,103166269,6758,Unspecified,,,,,Antifeedant activity against Diaprepes abbreviatus in compound treated healthy romaine lettuce plants assessed as area consumed from leaf disk at 48 g/l by choice tests (1.47 +/- 0.1 cm'2),Other,21370392.0,
2178,1105082,1,1,,103166269,6758,Unspecified,,,,,Antifeedant activity against Schistocerca americana in compound treated healthy romaine lettuce plants assessed as area consumed from leaf disk at 48 g/l by choice tests (1.88 +/- 0.2 cm'2),Other,21370392.0,
2179,1105525,1,1,,103166269,6758,Unspecified,,,,,Inhibition of Escherichia coli GR19N NDH2 assessed as deaminoNADH-DB reductase activity at 100 uM relative to control,Other,8573592.0,
2180,1105526,1,1,,103166269,6758,Active,,,12.5893,IC50,Inhibition of Escherichia coli GR19N NDH1 assessed as deaminoNADH-DB reductase activity,Confirmatory,8573592.0,
2181,1105527,1,1,,103166269,6758,Inactive,,,,,Inhibition of Solanum tuberosum (potato) inner mitochondrial membrane NDH2 assessed as deaminoNADH-DB reductase activity at 100 uM relative to control,Other,8573592.0,
2182,1105528,1,1,,103166269,6758,Active,,,5.01187,IC50,Inhibition of Solanum tuberosum (potato) submitochondrial particle NDH1 assessed as deaminoNADH-DB reductase activity,Confirmatory,8573592.0,
2183,1105529,2,3,,103166269,6758,Active,128632.0,,0.0257,IC50,Inhibition of Bos taurus (bovine) heart submitochondrial particle NDH1 assessed as NADH-DB reductase activity,Confirmatory,8573592.0,
2184,1108984,2,3,,103166269,6758,Active,9910647.0,281111.0,0.00016999999999999999,IC50,Inhibition of Bos taurus (bovine) heart mitochondrial NADPH oxidase activity assessed per mg protein,Confirmatory,,
2185,1110339,1,2,,103166269,6758,Active,,,,,Cytotoxicity against Spodoptera frugiperda (fall armyworm) Sf9 cells at 1 to 10 uM after 72 hr by trypan blue dye exclusion test,Other,,
2186,1110442,1,2,,103166269,6758,Inactive,,,,,Reduction of ATP level in Spodoptera frugiperda (fall armyworm) Sf9 cells at 0.1 to 10 uM after 4 hr by luminescent cell viability assay,Other,,
2187,1117298,1,2,,170466816,6758,Inactive,,,12.5893,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
2188,1117304,1,2,,170466816,6758,Active,,,10.0,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
2189,1117305,1,2,,170466816,6758,Active,,,8.9125,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
2190,1117310,1,1,,170466816,6758,Inactive,,,12.5893,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
2191,1117312,1,1,,170466816,6758,Active,,,8.912510000000001,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
2192,1117314,1,1,,170466816,6758,Inactive,,,10.0,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
2193,1117324,1,1,,170466816,6758,Inactive,,,10.0,IC50,VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50,Confirmatory,,
2194,1117325,1,1,,170466816,6758,Active,,,2.9875,IC50,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50,Confirmatory,,
2195,1117326,1,1,,170466816,6758,Active,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
2196,1117327,1,1,,170466816,6758,Active,,,0.2539,IC50,alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50,Confirmatory,,
2197,1117328,1,1,,170466816,6758,Inactive,,,,,human p70S6K1 kinase inhibition-screen,Screening,,
2198,1117329,1,1,,170466816,6758,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
2199,1117336,1,1,,170466816,6758,Inactive,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
2200,1117337,1,1,,170466816,6758,Active,,,0.0257,IC50,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50,Confirmatory,,
2201,1117340,1,1,,170466816,6758,Active,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
2202,1117341,1,1,,170466816,6758,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
2203,1117342,1,1,,170466816,6758,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
2204,1117343,1,1,,170466816,6758,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
2205,1117346,1,1,,170466816,6758,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
2206,1117347,1,1,,170466816,6758,Active,,,0.1532,IC50,Decreased HeLa cell count-IC50,Confirmatory,,
2207,1117348,1,1,,170466816,6758,Inactive,,,10.0,IC50,Increased HeLa cells in S-phase-IC50,Confirmatory,,
2208,1117349,1,1,,170466816,6758,Active,,,0.3111,IC50,Increased HeLa cells with 2N DNA content-IC50,Confirmatory,,
2209,1117350,1,1,,170466816,6758,Active,,,0.2229,IC50,Increased chromatin condensation in HeLa cells-IC50,Confirmatory,,
2210,1117351,1,1,,170466816,6758,Active,,,0.3108,IC50,Increased HeLa cells with 4N DNA content-IC50,Confirmatory,,
2211,1117353,1,1,,170466816,6758,Inactive,,,,,human KDR kinase inhibition-screen,Screening,,
2212,1117354,1,1,,170466816,6758,Inactive,,,,,human JAK2 kinase inhibition-screen,Screening,,
2213,1117355,1,1,,170466816,6758,Inactive,,,,,human GSK3B kinase inhibition-screen,Screening,,
2214,1117356,1,1,,170466816,6758,Inactive,,,,,human FLT3 kinase inhibition-screen,Screening,,
2215,1128688,1,2,,103166269,6758,Active,,,,,Induction of NAD(P)H oxidation in mouse TA3/Ha cells assessed as reduction of NAD(P)H/NAD(P)+ ratio at 12 uM by spectrofluorometer analysis,Other,24568614.0,
2216,1159387,1,2,,103166269,6758,Unspecified,,,,,"ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured  by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5",Other,,
2217,1159509,1,1,,144209102,6758,Inconclusive,119626539.0,4790.0,62.4754,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2218,1159509,1,1,,144211012,6758,Inconclusive,119626539.0,4790.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2219,1159509,1,1,,170466816,6758,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2220,1159515,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2221,1159515,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2222,1159515,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2223,1159516,1,1,,144209102,6758,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2224,1159516,1,1,,144211012,6758,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2225,1159516,1,1,,170466816,6758,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2226,1159517,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2227,1159517,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2228,1159517,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2229,1159518,1,1,,144209102,6758,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2230,1159518,1,1,,144211012,6758,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2231,1159518,1,1,,170466816,6758,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2232,1159519,1,1,,144209102,6758,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2233,1159519,1,1,,144211012,6758,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2234,1159519,1,1,,170466816,6758,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2235,1159520,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2236,1159520,1,1,,144211012,6758,Inconclusive,,,0.0969,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2237,1159520,1,1,,170466816,6758,Inconclusive,,,0.0944,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2238,1159521,1,1,,144209102,6758,Active,15928672.0,19885.0,0.0348,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2239,1159521,1,1,,144211012,6758,Active,15928672.0,19885.0,0.7696,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2240,1159521,1,1,,170466816,6758,Active,15928672.0,19885.0,0.0106,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2241,1159523,1,1,,144209102,6758,Active,15928672.0,19885.0,0.164804,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2242,1159523,1,1,,144211012,6758,Inconclusive,15928672.0,19885.0,0.27305999999999997,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2243,1159523,1,1,,170466816,6758,Active,15928672.0,19885.0,0.0573149,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2244,1159525,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2245,1159525,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2246,1159525,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2247,1159526,1,1,,144209102,6758,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2248,1159526,1,1,,144211012,6758,Inconclusive,119627033.0,3725.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2249,1159526,1,1,,170466816,6758,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2250,1159527,1,1,,144209102,6758,Inconclusive,325495497.0,6256.0,0.7865,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2251,1159527,1,1,,144211012,6758,Inconclusive,325495497.0,6256.0,13.8006,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2252,1159527,1,1,,170466816,6758,Inconclusive,325495497.0,6256.0,2.3914,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2253,1159528,1,1,,144209102,6758,Inconclusive,119627033.0,3725.0,1.17682,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2254,1159528,1,1,,144211012,6758,Inconclusive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2255,1159528,1,1,,170466816,6758,Inconclusive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2256,1159529,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2257,1159529,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2258,1159529,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2259,1159531,1,1,,144209102,6758,Inconclusive,325495497.0,6256.0,0.786518,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2260,1159531,1,1,,144211012,6758,Inconclusive,325495497.0,6256.0,0.837973,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2261,1159531,1,1,,170466816,6758,Inconclusive,325495497.0,6256.0,1.9739099999999998,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2262,1159550,3,1,,252402767,6758,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
2263,1159551,1,1,,144209102,6758,Inconclusive,,,2.7667,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2264,1159551,1,1,,144211012,6758,Inconclusive,,,15.3553,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2265,1159551,1,1,,170466816,6758,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2266,1159552,1,1,,144209102,6758,Inconclusive,325495463.0,5914.0,7.7977,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2267,1159552,1,1,,144211012,6758,Inconclusive,325495463.0,5914.0,1.3685,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2268,1159552,1,1,,170466816,6758,Inconclusive,325495463.0,5914.0,0.6682,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2269,1159553,2,1,,144209102,6758,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2270,1159553,2,1,,144211012,6758,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2271,1159553,2,1,,170466816,6758,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2272,1159555,1,1,,144209102,6758,Active,325495463.0,5914.0,8.259780000000001,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2273,1159555,1,1,,144211012,6758,Active,325495463.0,5914.0,3.43762,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2274,1159555,1,1,,170466816,6758,Active,325495463.0,5914.0,4.38128,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2275,1159580,2,1,,268735524,6758,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
2276,1159607,2,1,,312995650,6758,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
2277,1159614,1,2,,170466816,6758,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
2278,1161119,1,1,,103166269,6758,Inactive,,,,IC50,Inhibition of NDH2 in Mycobacterium smegmatis (MC2) 155 membranes assessed NADH oxidation relative to control,Confirmatory,25150092.0,
2279,1224818,1,1,,312345235,6758,Inconclusive,,,0.9439,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway - cell viability counter screen,Confirmatory,,
2280,1224819,1,1,,312345235,6758,Active,325495545.0,2101.0,0.0668,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
2281,1224820,1,1,,312345235,6758,Inactive,325495545.0,2101.0,0.075,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
2282,1224821,1,1,,312345235,6758,Active,325495545.0,2101.0,0.0188,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
2283,1224822,1,1,,312345235,6758,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) ### cell viability counter screen,Confirmatory,,
2284,1224823,1,1,,312345235,6758,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
2285,1224824,1,1,,174007489,6758,Inactive,,,1.0490000000000002,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
2286,1224825,1,1,,174007489,6758,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
2287,1224834,3,1,,144209102,6758,Active,,,8.7492,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
2288,1224834,3,1,,144211012,6758,Active,,,8.6349,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
2289,1224834,3,1,,170466816,6758,Active,,,0.3758,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
2290,1224835,1,1,,144209102,6758,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
2291,1224835,1,1,,144211012,6758,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
2292,1224835,1,1,,170466816,6758,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
2293,1224836,1,1,,144209102,6758,Active,,,0.8749,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2294,1224836,1,1,,144211012,6758,Active,,,1.5355,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2295,1224836,1,1,,170466816,6758,Active,,,0.6682,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2296,1224837,1,1,,144209102,6758,Active,,,1.9587,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2297,1224837,1,1,,144211012,6758,Active,,,0.7696,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2298,1224837,1,1,,170466816,6758,Active,,,0.5308,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2299,1224838,1,1,,144209102,6758,Active,66775687.0,9970.0,3.4831,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2300,1224838,1,1,,144211012,6758,Active,66775687.0,9970.0,19.3312,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2301,1224838,1,1,,170466816,6758,Active,66775687.0,9970.0,3.3491,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2302,1224839,1,1,,144209102,6758,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2303,1224839,1,1,,144211012,6758,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2304,1224839,1,1,,170466816,6758,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2305,1224840,3,1,,144209102,6758,Inconclusive,,,12.3586,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
2306,1224840,3,1,,144211012,6758,Inconclusive,,,3.8571,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
2307,1224840,3,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
2308,1224841,3,1,,144209102,6758,Active,325495545.0,2101.0,0.0348,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2309,1224841,3,1,,144211012,6758,Active,325495545.0,2101.0,0.0049,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2310,1224841,3,1,,170466816,6758,Inconclusive,325495545.0,2101.0,0.0075,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2311,1224842,3,1,,144209102,6758,Inactive,325495545.0,2101.0,0.0055,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2312,1224842,3,1,,144211012,6758,Inactive,325495545.0,2101.0,0.0039,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2313,1224842,3,1,,170466816,6758,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2314,1224843,1,1,,144209102,6758,Active,119601739.0,7253.0,24.6586,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2315,1224843,1,1,,144211012,6758,Active,119601739.0,7253.0,17.2289,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2316,1224843,1,1,,170466816,6758,Active,119601739.0,7253.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2317,1224844,1,1,,144209102,6758,Inconclusive,,,0.701,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
2318,1224844,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
2319,1224844,1,1,,170466816,6758,Inconclusive,,,0.4253,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
2320,1224845,1,1,,144209102,6758,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
2321,1224845,1,1,,144211012,6758,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
2322,1224845,1,1,,170466816,6758,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
2323,1224846,1,1,,144209102,6758,Inconclusive,11995455.0,3091.0,55.6812,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
2324,1224846,1,1,,144211012,6758,Inconclusive,11995455.0,3091.0,4.8966,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
2325,1224846,1,1,,170466816,6758,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
2326,1224847,1,1,,144209102,6758,Active,,,0.091,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
2327,1224847,1,1,,144211012,6758,Inconclusive,,,4.0095,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
2328,1224847,1,1,,170466816,6758,Inconclusive,,,27.6638,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
2329,1224848,3,1,,144209102,6758,Active,325495545.0,2101.0,0.0391,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2330,1224848,3,1,,144211012,6758,Active,325495545.0,2101.0,0.0097,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2331,1224848,3,1,,170466816,6758,Active,325495545.0,2101.0,0.0106,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2332,1224849,3,1,,144209102,6758,Inactive,325495545.0,2101.0,0.0492,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2333,1224849,3,1,,144211012,6758,Inactive,325495545.0,2101.0,0.0109,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2334,1224849,3,1,,170466816,6758,Inactive,325495545.0,2101.0,0.0084,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2335,1224857,2,1,,170466816,6758,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
2336,1224857,2,1,,174007489,6758,Inactive,,,2.3485,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
2337,1224857,2,1,,312345235,6758,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
2338,1224859,2,1,,90340839,6758,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
2339,1224859,2,1,,170466816,6758,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
2340,1224859,2,1,,174007489,6758,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
2341,1224867,1,1,,144209102,6758,Active,,,27.9067,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
2342,1224867,1,1,,144211012,6758,Active,,,27.5357,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
2343,1224867,1,1,,170466816,6758,Inconclusive,,,8.4852,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
2344,1224868,1,1,,144209102,6758,Active,,,0.0557,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
2345,1224868,1,1,,144211012,6758,Active,,,0.011000000000000001,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
2346,1224868,1,1,,170466816,6758,Active,,,0.0477,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
2347,1224869,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
2348,1224869,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
2349,1224869,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
2350,1224870,1,1,,144209102,6758,Active,,,44.2292,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
2351,1224870,1,1,,144211012,6758,Active,,,27.5357,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
2352,1224870,1,1,,170466816,6758,Inconclusive,,,13.4481,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
2353,1224871,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
2354,1224871,1,1,,144211012,6758,Inconclusive,,,61.6448,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
2355,1224871,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
2356,1224872,1,1,,144209102,6758,Active,,,0.0882,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
2357,1224872,1,1,,144211012,6758,Active,,,0.0155,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
2358,1224872,1,1,,170466816,6758,Active,,,0.1068,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
2359,1224873,1,1,,144209102,6758,Inconclusive,,,31.3119,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
2360,1224873,1,1,,144211012,6758,Active,,,24.5412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
2361,1224873,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
2362,1224874,1,1,,144209102,6758,Active,,,0.0557,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
2363,1224874,1,1,,144211012,6758,Active,,,0.011000000000000001,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
2364,1224874,1,1,,170466816,6758,Active,,,0.0477,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
2365,1224875,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
2366,1224875,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
2367,1224875,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
2368,1224876,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
2369,1224876,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
2370,1224876,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
2371,1224877,1,1,,144209102,6758,Active,,,44.2292,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
2372,1224877,1,1,,144211012,6758,Active,,,27.5357,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
2373,1224877,1,1,,170466816,6758,Inconclusive,,,9.5205,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
2374,1224878,1,1,,144209102,6758,Active,,,49.626000000000005,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
2375,1224878,1,1,,144211012,6758,Active,,,38.8952,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
2376,1224878,1,1,,170466816,6758,Inconclusive,,,26.8325,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
2377,1224879,1,1,,144209102,6758,Active,,,24.8719,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
2378,1224879,1,1,,144211012,6758,Active,,,24.5412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
2379,1224879,1,1,,170466816,6758,Inconclusive,,,30.1065,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
2380,1224880,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
2381,1224880,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
2382,1224880,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
2383,1224881,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
2384,1224881,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
2385,1224881,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
2386,1224882,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
2387,1224882,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
2388,1224882,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
2389,1224883,1,1,,144209102,6758,Active,,,27.9067,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
2390,1224883,1,1,,144211012,6758,Active,,,24.5412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
2391,1224883,1,1,,170466816,6758,Inconclusive,,,33.7801,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
2392,1224884,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
2393,1224884,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
2394,1224884,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
2395,1224885,1,1,,144209102,6758,Active,,,31.3119,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
2396,1224885,1,1,,144211012,6758,Active,,,27.5357,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
2397,1224885,1,1,,170466816,6758,Inconclusive,,,9.5205,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
2398,1224886,1,1,,144209102,6758,Active,,,0.0625,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
2399,1224886,1,1,,144211012,6758,Active,,,0.0123,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
2400,1224886,1,1,,170466816,6758,Active,,,0.0477,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
2401,1224887,1,1,,144209102,6758,Active,,,0.2487,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
2402,1224887,1,1,,144211012,6758,Active,,,0.2187,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
2403,1224887,1,1,,170466816,6758,Active,,,0.0601,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
2404,1224888,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
2405,1224888,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
2406,1224888,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
2407,1224889,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
2408,1224889,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
2409,1224889,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
2410,1224890,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
2411,1224890,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
2412,1224890,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
2413,1224892,1,1,,144209102,6758,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2414,1224892,1,1,,144211012,6758,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2415,1224892,1,1,,170466816,6758,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2416,1224893,1,1,,144209102,6758,Inconclusive,66775687.0,9970.0,2.28368,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2417,1224893,1,1,,144211012,6758,Inconclusive,66775687.0,9970.0,6.60073,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2418,1224893,1,1,,170466816,6758,Inconclusive,66775687.0,9970.0,5.30804,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2419,1224894,1,1,,144209102,6758,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2420,1224894,1,1,,144211012,6758,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2421,1224894,1,1,,170466816,6758,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2422,1224895,1,1,,144209102,6758,Active,119601739.0,7253.0,21.1496,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2423,1224895,1,1,,144211012,6758,Active,119601739.0,7253.0,23.4203,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2424,1224895,1,1,,170466816,6758,Active,119601739.0,7253.0,28.7255,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2425,1224896,1,1,,144209102,6758,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2426,1224896,1,1,,144211012,6758,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2427,1224896,1,1,,170466816,6758,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2428,1224905,2,1,,121362050,6758,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
2429,1224905,2,1,,121362050,6758,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
2430,1259241,1,1,,144209102,6758,Inconclusive,,,0.1556,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2431,1259241,1,1,,144211012,6758,Active,,,0.0486,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2432,1259241,1,1,,170466816,6758,Inconclusive,,,0.1679,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2433,1259242,1,1,,144209102,6758,Active,,,0.078,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2434,1259242,1,1,,144211012,6758,Active,,,0.0545,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2435,1259242,1,1,,170466816,6758,Active,,,0.1059,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2436,1259243,1,1,,144209102,6758,Active,124375976.0,367.0,0.031,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2437,1259243,1,1,,144211012,6758,Active,124375976.0,367.0,0.0193,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2438,1259243,1,1,,170466816,6758,Active,124375976.0,367.0,0.0473,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2439,1259244,1,1,,144209102,6758,Active,348019627.0,2099.0,0.0175,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2440,1259244,1,1,,144211012,6758,Active,348019627.0,2099.0,0.0193,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2441,1259244,1,1,,170466816,6758,Active,348019627.0,2099.0,0.0531,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2442,1259247,1,1,,144209102,6758,Inconclusive,124375976.0,367.0,0.00847187,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2443,1259247,1,1,,144211012,6758,Inconclusive,124375976.0,367.0,0.00720287,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2444,1259247,1,1,,170466816,6758,Inconclusive,124375976.0,367.0,0.0510819,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2445,1259248,1,1,,144209102,6758,Active,348019627.0,2099.0,0.0110146,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2446,1259248,1,1,,144211012,6758,Inconclusive,348019627.0,2099.0,0.00685896,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2447,1259248,1,1,,170466816,6758,Active,348019627.0,2099.0,0.0421632,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2448,1259252,1,1,,174007489,6758,Active,169655958.0,,2.0931,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
2449,1259253,1,1,,174007489,6758,Active,169655958.0,,4.6859,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
2450,1259255,1,1,,174007489,6758,Active,169655958.0,,2.9566,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
2451,1259256,1,1,,174007489,6758,Active,169655958.0,,0.7427,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
2452,1259310,1,1,,321942680,6758,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
2453,1259310,1,1,,332950243,6758,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
2454,1259310,1,1,,332950403,6758,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
2455,1259344,1,1,,144204370,6758,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
2456,1259354,1,1,,348422237,6758,Inconclusive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
2457,1259354,1,1,,348463229,6758,Inactive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
2458,1259355,1,1,,26753652,6758,Inconclusive,,,28.1838,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
2459,1259356,1,1,,144204370,6758,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
2460,1259364,1,1,,144209102,6758,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2461,1259364,1,1,,144211012,6758,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2462,1259364,1,1,,170466816,6758,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2463,1259365,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2464,1259365,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2465,1259365,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2466,1259366,1,1,,144209102,6758,Active,,,24.6586,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2467,1259366,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2468,1259366,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2469,1259367,1,1,,144209102,6758,Active,,,21.976999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2470,1259367,1,1,,144211012,6758,Active,,,6.1131,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2471,1259367,1,1,,170466816,6758,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2472,1259368,1,1,,144209102,6758,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2473,1259368,1,1,,144211012,6758,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2474,1259368,1,1,,170466816,6758,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2475,1259369,1,1,,144209102,6758,Active,109731339.0,2737.0,0.0196,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2476,1259369,1,1,,144211012,6758,Active,109731339.0,2737.0,5.4483,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2477,1259369,1,1,,170466816,6758,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2478,1259370,2,2,,124637711,6758,Inactive,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
2479,1259370,2,2,,124637711,6758,Inactive,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
2480,1259370,2,2,,124637711,6758,Inactive,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
2481,1259377,1,1,,144209102,6758,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2482,1259377,1,1,,144211012,6758,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2483,1259377,1,1,,170466816,6758,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2484,1259378,1,1,,144209102,6758,Inconclusive,54288833.0,2100.0,21.976999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2485,1259378,1,1,,144211012,6758,Active,54288833.0,2100.0,19.3312,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2486,1259378,1,1,,170466816,6758,Active,54288833.0,2100.0,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2487,1259379,1,1,,144209102,6758,Active,,,0.0552,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2488,1259379,1,1,,144211012,6758,Active,,,0.0386,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2489,1259379,1,1,,170466816,6758,Active,,,0.0473,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2490,1259380,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2491,1259380,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2492,1259380,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2493,1259381,1,1,,144209102,6758,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2494,1259381,1,1,,144211012,6758,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2495,1259381,1,1,,170466816,6758,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2496,1259382,1,1,,144209102,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2497,1259382,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2498,1259382,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2499,1259383,1,1,,144209102,6758,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2500,1259383,1,1,,144211012,6758,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2501,1259383,1,1,,170466816,6758,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2502,1259384,1,1,,144209102,6758,Inconclusive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2503,1259384,1,1,,144211012,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2504,1259384,1,1,,170466816,6758,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2505,1259385,1,1,,144209102,6758,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2506,1259385,1,1,,144211012,6758,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2507,1259385,1,1,,170466816,6758,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2508,1259386,1,1,,144209102,6758,Active,,,2.7667,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2509,1259386,1,1,,144211012,6758,Active,,,0.0969,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2510,1259386,1,1,,170466816,6758,Active,,,0.1883,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2511,1259387,1,1,,144209102,6758,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2512,1259387,1,1,,144211012,6758,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2513,1259387,1,1,,170466816,6758,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2514,1259388,1,1,,144209102,6758,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2515,1259388,1,1,,144211012,6758,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2516,1259388,1,1,,170466816,6758,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2517,1259389,1,1,,124637711,6758,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
2518,1259390,1,1,,144209102,6758,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2519,1259390,1,1,,144211012,6758,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2520,1259390,1,1,,170466816,6758,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2521,1259391,1,1,,144209102,6758,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2522,1259391,1,1,,144211012,6758,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2523,1259391,1,1,,170466816,6758,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2524,1259392,1,1,,144209102,6758,Active,109731339.0,2737.0,0.105999,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2525,1259392,1,1,,144211012,6758,Inconclusive,109731339.0,2737.0,0.647528,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2526,1259392,1,1,,170466816,6758,Active,109731339.0,2737.0,0.00325437,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2527,1259393,1,1,,144209102,6758,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2528,1259393,1,1,,144211012,6758,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2529,1259393,1,1,,170466816,6758,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2530,1259394,1,1,,144209102,6758,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2531,1259394,1,1,,144211012,6758,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2532,1259394,1,1,,170466816,6758,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2533,1259395,1,1,,144209102,6758,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2534,1259395,1,1,,144211012,6758,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2535,1259395,1,1,,170466816,6758,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2536,1259396,1,1,,144209102,6758,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2537,1259396,1,1,,144211012,6758,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2538,1259396,1,1,,170466816,6758,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2539,1259400,1,1,,170466816,6758,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
2540,1259401,1,1,,144209102,6758,Inconclusive,325495545.0,2101.0,0.0246586,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2541,1259401,1,1,,144211012,6758,Active,325495545.0,2101.0,0.00485577,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2542,1259401,1,1,,170466816,6758,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2543,1259402,1,1,,144209102,6758,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2544,1259402,1,1,,144211012,6758,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2545,1259402,1,1,,170466816,6758,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2546,1259403,1,1,,144209102,6758,Active,325495545.0,2101.0,0.0161672,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2547,1259403,1,1,,144211012,6758,Inconclusive,325495545.0,2101.0,0.005882899999999999,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2548,1259403,1,1,,170466816,6758,Active,325495545.0,2101.0,0.012831200000000001,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2549,1259404,1,1,,144209102,6758,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2550,1259404,1,1,,144211012,6758,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2551,1259404,1,1,,170466816,6758,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2552,1259407,1,1,,363898845,6758,Active,,,,,CCRIS mutagenicity studies,Other,,
2553,1259408,1,1,,363895080,6758,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
2554,1259409,1,1,,363898845,6758,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
2555,1259411,1,1,,363898845,6758,Unspecified,,,,,CCRIS carcinogenicity studies,Other,,
2556,1259416,1,2,,375172229,6758,Inconclusive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
2557,1259421,1,1,,375172229,6758,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
2558,1259423,1,2,,354781437,6758,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
2559,1259423,1,2,,354958706,6758,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
